Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1050.Time spend outdoors in summer,45245,0.0372883345305504,0.0335487206566358,-0.0284671579564558,0.103043827017557,0.266379387641704
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1060.Time spent outdoors in winter,42046,0.0235853532559597,0.0383873000911842,-0.0516537549227613,0.0988244614346808,0.538955347860328
CCND2,G1/S-specific cyclin-D2,Physical activities,X1070.Time spent watching television (TV),46288,0.00294169000240582,0.0333276423117042,-0.0623804889285344,0.0682638689333461,0.929666232617297
CCND2,G1/S-specific cyclin-D2,Physical activities,X1080.Time spent using computer,42053,-0.117713006309134,0.0362710764334076,-0.188804316118613,-0.0466216964996556,0.00117510752100106
CCND2,G1/S-specific cyclin-D2,Physical activities,X1090.Time spent driving,41081,-0.0713781302908608,0.0380473399782043,-0.145950916648141,0.00319465606641953,0.0606674161373814
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1160.Sleep duration,47806,-0.0450805989595276,0.0313404865195113,-0.10650795253777,0.0163467546187146,0.150329652594772
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32549,0.00214653253498501,0.0133249904638908,-0.023970448774241,0.0282635138442111,0.872025680849358
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32549,0.00465837997498787,0.0131137268186433,-0.0210445245895531,0.0303612845395288,0.722426439630615
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32549,0.0127307606314197,0.0152695228751008,-0.0171975042037779,0.0426590254666173,0.404452327107056
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32549,0.0155159484447823,0.0157836568762203,-0.0154200190326095,0.046451915922174,0.325615672369736
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32549,0.0142553236779647,0.0161661031347819,-0.0174302384662078,0.0459408858221372,0.377907559367482
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32549,0.0212860164642555,0.0309749822886941,-0.0394249488215849,0.0819969817500959,0.491974869481921
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32549,-0.0106517060767995,0.0317688605894514,-0.0729186728321242,0.0516152606785252,0.737416215922625
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32549,0.0160837472356371,0.0226160216591159,-0.02824365521623,0.0604111496875043,0.477000421650762
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32549,-0.0160171431127959,0.0170095935443493,-0.0493559464597205,0.0173216602341287,0.346396253454546
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32549,0.0144701192079773,0.0118935833759942,-0.00884130420897139,0.037781542624926,0.223777145568716
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32549,0.0195696647571575,0.0168019749690671,-0.013362206182214,0.052501535696529,0.244162676519467
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32549,0.00119855354868028,0.00965509056919884,-0.0177254239669494,0.02012253106431,0.901209709603384
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32549,-0.000958566047530519,0.0123651662481731,-0.0251942918939498,0.0232771597988888,0.938210485229989
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32549,-0.00171354683892459,0.0186860902881513,-0.0383382838037012,0.034911190125852,0.926937135397884
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32549,-0.0103700950155277,0.0174234909059682,-0.0445201371912254,0.0237799471601699,0.551739359392822
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32549,0.0359964283098262,0.0214828252277314,-0.00610990913652729,0.0781027657561798,0.0938543157666592
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32549,-0.00671653417964877,0.0207111446663543,-0.0473103777257032,0.0338773093664057,0.74572201670469
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32549,0.00792542783193176,0.0138108070531432,-0.0191437539922288,0.0349946096560924,0.566079449541381
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32549,0.00755748564933699,0.0129854633034636,-0.0178940224254518,0.0330089937241257,0.560584580983915
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32549,0.0108963012443799,0.016108386552554,-0.0206761363986259,0.0424687388873857,0.498781530341062
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120040.Fatigue severity over the past week,32558,-0.0625119971494131,0.0534593091289348,-0.167292243042125,0.0422682487432991,0.242299562806695
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120041.Waking unrefreshed severity over the past week,32560,-0.0305186307090525,0.0532588111336758,-0.134905900531057,0.0738686391129521,0.566642573956263
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120042.Cognitive symptoms severity over the past week,32558,0.0694650193249617,0.0586402618159253,-0.0454698938342519,0.184399932484175,0.236209595636257
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120098.Mobility problems today,32562,-0.0204187527772172,0.0654271296951898,-0.148655926979789,0.107818421425355,0.754984253542877
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120099.Self-care problems today,32562,-0.0242052362928546,0.101682781474834,-0.22350348798353,0.175093015397821,0.811850589248589
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120100.Problems doing usual activities,32562,-0.0640442260997849,0.0616506072269682,-0.184879416264643,0.0567909640650728,0.2989147482846
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120101.Pain or discomfort today,32562,0.074520084146716,0.0538513392694506,-0.0310285408214072,0.180068709114839,0.166451789951374
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120102.Anxiety or depression today,32562,0.0430376090006386,0.0641329670603831,-0.0826630064377123,0.168738224438989,0.502194760055135
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120103.Scale to indicate how health is today,32531,0.00111529268622935,0.00414728084075894,-0.00701337776165817,0.00924396313411687,0.787996545068901
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32546,0.0721820555505451,0.0646785396821418,-0.0545878822264527,0.198951993327543,0.264447684992669
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32532,-0.0516399949153639,0.0657272546201312,-0.180465413970821,0.0771854241400931,0.432081753601053
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32551,-0.00493012603103463,0.0531112926864792,-0.109028259696534,0.0991680076344645,0.926043678328145
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32554,-0.0306197666834952,0.0545662396439063,-0.137569596385551,0.076330063018561,0.574710733899958
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32550,0.0411191409032,0.0669706341498844,-0.0901433020305735,0.172381583836973,0.539239577856837
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120109.Feeling bad about self over the last two weeks,32528,0.0187761913297334,0.0687073119467595,-0.115890140085915,0.153442522745382,0.784646098621022
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120110.Trouble concentrating over the last two weeks,32554,0.0904207624716527,0.0693802617183751,-0.0455645504963624,0.226406075439668,0.192519339442118
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32542,0.0164160786950845,0.10406777523678,-0.187556760769004,0.220388918159173,0.874662109269738
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32498,-0.00256307266046958,0.136475744653532,-0.270055532181392,0.264929386860453,0.98501670249518
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",30075,-0.0223865414223164,0.0724270922248132,-0.16434364218295,0.119570559338317,0.757262889327567
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45132,-0.003792182667088,0.0751144052868378,-0.15101641702929,0.143432051695114,0.959736037869771
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43997,0.0520778308520601,0.0458450351951192,-0.0377784381303735,0.141934099834494,0.255989521183165
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1289.Cooked vegetable intake,46919,-0.0762228584241607,0.032351481485002,-0.139631762134765,-0.0128139547135568,0.0184769843554853
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46476,-0.0100886475604151,0.0347769927239475,-0.0782515532993522,0.058074258178522,0.771745871779117
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1309.Fresh fruit intake,46915,0.00908855610022482,0.0343253067604908,-0.0581890451503372,0.0763661573507868,0.791183525465365
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1319.Dried fruit intake,45624,0.0280560916426081,0.0362565666759802,-0.0430067790423132,0.0991189623275293,0.439045074591558
CCND2,G1/S-specific cyclin-D2,Health and medical history,X134.Number of self-reported cancers,48007,0.0779226045417798,0.0715041648567799,-0.0622255585775087,0.218070767661068,0.27582836289587
CCND2,G1/S-specific cyclin-D2,Health and medical history,X135.Number of self-reported non-cancer illnesses,48007,-0.0292802757214562,0.0315799403649263,-0.0911769588367118,0.0326164073937994,0.353842572508423
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X136.Number of operations, self-reported",48007,-0.0165686214781142,0.0316231681884483,-0.0785500311274729,0.0454127881712444,0.600325548983526
CCND2,G1/S-specific cyclin-D2,Health and medical history,X137.Number of treatments or medications taken,48007,-0.0197841127504758,0.0314200897036804,-0.0813674885696893,0.0417992630687377,0.528920119761303
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1438.Bread intake,47264,0.00304021796573442,0.00260152405702526,-0.00205876918603509,0.00813920511750393,0.242564808422228
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1458.Cereal intake,46588,-0.0131978550968053,0.0325810927808929,-0.0770567969473553,0.0506610867537447,0.685424639705385
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1488.Tea intake,47061,0.0021932954223775,0.00247172551979797,-0.00265128659642653,0.00703787744118153,0.374897562090105
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1498.Coffee intake,46036,0.00585838198860146,0.0325657816656515,-0.0579705500760756,0.0696873140532785,0.857237591857214
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1528.Water intake,46307,-0.0145390464578737,0.0333681544670913,-0.0799406292133727,0.0508625362976253,0.663046818867933
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1568.Average weekly red wine intake,40204,-0.121681484692403,0.0383280783958735,-0.196804518348315,-0.0465584510364911,0.00150251703122549
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,40198,-0.0284324985079757,0.0394239131744883,-0.105703368329973,0.0488383713140214,0.470797223948925
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1588.Average weekly beer plus cider intake,40240,0.00123429216290942,0.0431543333511715,-0.0833482012053867,0.0858167855312056,0.977182514758397
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1598.Average weekly spirits intake,40173,0.102812407914894,0.0434947273791548,0.0175627422517512,0.188062073578038,0.0181007089282299
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1608.Average weekly fortified wine intake,40230,0.110131384307849,0.0792497041603408,-0.0451980358464186,0.265460804462117,0.164646291296129
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1737.Childhood sunburn occasions,42368,-0.06708448566692,0.0381261488592978,-0.141811737431144,0.0076427660973038,0.0785023451359422
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1807.Father's age at death,38314,0.00028838564184757,0.00347820092717112,-0.00652888817540783,0.00710565945910297,0.933922421147155
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1845.Mother's age,37596,-0.0058875878348539,0.00536706091201071,-0.0164070272223949,0.00463185155268709,0.272666974539569
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1873.Number of full brothers,47572,-0.0122277455625989,0.0316127688828497,-0.0741887725729843,0.0497332814477866,0.698909468390884
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1883.Number of full sisters,47573,0.0498630050583051,0.0318212083031158,-0.0125065632158019,0.112232573332412,0.117134120365741
CCND2,G1/S-specific cyclin-D2,Physical measures,X20015.Sitting height,47803,-0.00419727809007432,0.00329934351780223,-0.0106639913849667,0.00226943520481805,0.203330220642612
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20016.Fluid intelligence score,31568,-0.0305728953392824,0.0539398593214214,-0.136295019609268,0.0751492289307036,0.570869332702834
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20018.Prospective memory result,31865,-0.15125357740794,0.0758612827297882,-0.299941691558325,-0.00256546325755541,0.0462058420811727
CCND2,G1/S-specific cyclin-D2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31490,-0.00128566744159317,0.00450910561102895,-0.0101235144392099,0.00755217955602357,0.775554637436949
CCND2,G1/S-specific cyclin-D2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31494,0.000596768074613542,0.00445458709160153,-0.00813422262492546,0.00932775877415255,0.893432128728569
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20023.Mean time to correctly identify matches,47735,-0.00205575372454216,0.00262172479204172,-0.00719433431694393,0.0030828268678596,0.432975940415675
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45226,-0.00157365848309323,0.00570560821870413,-0.0127566505917533,0.00960933362556686,0.782697386172307
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44854,0.0216961193188179,0.013038961776516,-0.00386024576315352,0.0472524844007893,0.0961382831680833
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44827,-0.000464902050296746,0.0173661400412756,-0.034502536531197,0.0335727324306035,0.978642954551427
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#12.Illnesses of father_Severe depression,44853,-0.0210865893142963,0.0133002215567326,-0.0471550235654922,0.00498184493689959,0.112883406266949
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44856,0.0169335167278621,0.00970652248000998,-0.00209126733295748,0.0359583007886816,0.0810778100077873
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#2.Illnesses of father_Stroke,44991,0.00921605149195778,0.00747702113294678,-0.00543890992861791,0.0238710129125335,0.217744978454265
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44939,-0.012948907659706,0.00978989098447136,-0.0321370939892698,0.0062392786698579,0.18595566885737
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44857,-0.00692993217367003,0.011848396113801,-0.03015278855672,0.0162929242093799,0.558632294039146
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44975,0.00640156649731843,0.0092980302124163,-0.0118225727190175,0.0246257057136544,0.491154153308838
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45091,0.000775181675400951,0.00591349186993691,-0.0108152623896754,0.0123656257404773,0.895707758169096
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#9.Illnesses of father_Diabetes,44965,0.0143427632171935,0.00802566050561295,-0.00138753137380783,0.0300730578081949,0.0739335528737814
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46097,-0.00138056438611952,0.00681337748366701,-0.0147347842541069,0.0119736554818678,0.839429568993752
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,45992,0.00286081979956198,0.0109904468743799,-0.0186804560742227,0.0244020956733467,0.794634339504328
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45943,-0.0389069772313837,0.0236693790671062,-0.085298960202912,0.00748500574014451,0.100238287466984
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,45984,0.00897892340282349,0.00991327776915305,-0.0104511010247165,0.0284089478303635,0.365079546768669
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46043,-0.00122388867759408,0.00811056883079407,-0.0171206035859505,0.0146728262307623,0.880055598987009
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,45985,-0.00651040481008939,0.0132303893922341,-0.0324419680188683,0.0194211583986895,0.622667950434443
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,45965,-0.00644618933128648,0.0123868952081146,-0.0307245039391911,0.0178321252766182,0.602787261862428
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,45995,0.0101580749165963,0.00949499714171764,-0.00845211948117027,0.0287682693143629,0.28470550448025
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46002,0.00962165688879384,0.0111158290847411,-0.0121653681172986,0.0314086818948863,0.386729039406055
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46194,-0.0056539369714193,0.00536221616632302,-0.0161638806574124,0.00485600671457382,0.291709842065754
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46048,-0.00623622945869942,0.00829843388943933,-0.0225011598820005,0.0100287009646017,0.452362932908511
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43659,-0.0100399948076599,0.0110150327111435,-0.0316294589215012,0.0115494693061814,0.362053004417512
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43566,-0.0746860701700687,0.062268934728079,-0.196733182237104,0.0473610418969662,0.230382438107341
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43565,-0.0426981187867563,0.0532724030079999,-0.147112028682436,0.0617157911089235,0.422848782749992
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43642,0.00503660281047325,0.0100609461262488,-0.0146828515969745,0.024756057217921,0.616651712495416
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43569,-0.0408645246077388,0.0343058515481338,-0.108103993642081,0.0263749444266035,0.233596354668452
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43583,-0.00583057713376045,0.0188304918779931,-0.0427383412146269,0.031077186947106,0.756841898025359
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43570,0.015628434443584,0.0247492464156448,-0.0328800885310798,0.0641369574182479,0.527739847472552
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43581,-0.0161645421120934,0.022703717864241,-0.0606638291260058,0.0283347449018191,0.476486972324758
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43583,0.0145093386070761,0.0150677262587108,-0.015023404859997,0.0440420820741492,0.335588697924701
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43587,0.0178744376935065,0.0197386438833791,-0.0208133043179166,0.0565621797049296,0.365182226705464
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43743,0.000904889813692653,0.00706462026952234,-0.0129417659145711,0.0147515455419564,0.898080993851172
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43648,-0.00344969054910956,0.0102908326459789,-0.0236197225352281,0.016720341437009,0.737462863395648
CCND2,G1/S-specific cyclin-D2,Mental health,X20127.Neuroticism score,43194,0.0687209031129694,0.032701929847753,0.00462512061137349,0.132816685614565,0.035615919239955
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,31568,-0.0506625384171556,0.0542702546728375,-0.157032237575917,0.0557071607416058,0.35057921288086
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X20161.Pack years of smoking,30629,0.00152103007285303,0.00536006718863479,-0.00898470161687115,0.0120267617625772,0.776594780943212
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30629,0.00133597759291935,0.00500806116474747,-0.00847982228998569,0.0111517774758244,0.789657898418817
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20191.Fluid intelligence score,30052,0.0278132158910661,0.0567190812656126,-0.0833561833895347,0.138982615171667,0.623891006993113
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,30052,-0.0368694556767556,0.0579475320537162,-0.150446618502039,0.0767077071485282,0.524633245557572
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20240.Maximum digits remembered correctly,29510,-0.0694844085346656,0.0613759936171815,-0.189781356024341,0.0508125389550101,0.25763608167563
CCND2,G1/S-specific cyclin-D2,Physical measures,X20255.Spirometry QC measure,41791,-0.0655922308025915,0.0416750584851984,-0.14727534543358,0.0160908838283973,0.115529008218196
CCND2,G1/S-specific cyclin-D2,Eye measures,X20261.avMSE,29134,-0.00136340054725841,0.00563489905430541,-0.012407802693697,0.00968100159918019,0.808823264092306
CCND2,G1/S-specific cyclin-D2,Eye measures,X20262.Myopia diagnosis,29134,0.00891238860678382,0.0780929921179545,-0.144149875944407,0.161974653157975,0.909142786804719
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X20280.Glucose-lactate,37139,0.00346679209116898,0.00342030883620953,-0.0032370132278017,0.0101705974101397,0.310796723392828
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X20281.Spectrometer-corrected alanine,37166,-0.012032199419229,0.00337679575763889,-0.0186507191042012,-0.00541367973425678,0.000367642704580264
CCND2,G1/S-specific cyclin-D2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31347,-0.00576096940192291,0.0160042073738771,-0.0371292158547221,0.0256072770508763,0.718882764712372
CCND2,G1/S-specific cyclin-D2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31345,0.0107637110048712,0.0321263838403819,-0.0522040013222773,0.0737314233320197,0.737602250037851
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31346,0.0109798925578627,0.036113399108494,-0.0598023696947855,0.081762154810511,0.761106401416572
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31346,-0.0136807808802342,0.015490960370795,-0.0440430632069923,0.016681501446524,0.377185710765282
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31346,0.0140472017070969,0.0244707636158561,-0.0339154949799811,0.0620098983941748,0.565957854123007
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31350,-0.0488350581502387,0.0319327213691043,-0.111423192033683,0.0137530757332058,0.126229623202603
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31350,-0.00596747212951321,0.0213303419704019,-0.0477749423915009,0.0358399981324744,0.779665926437388
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31350,0.00506677144301131,0.0232576329892506,-0.0405181892159198,0.0506517321019424,0.8275487007949
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31350,0.00833910901476466,0.0360808556413977,-0.0623793680423749,0.0790575860719042,0.81722570211924
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31350,-0.0255034201233523,0.0414767591799735,-0.1067978681161,0.0557910278693958,0.538649618535075
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31350,0.00918240913516812,0.0242542746675095,-0.0383559692131504,0.0567207874834867,0.705003591080298
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31350,-0.0269716762668789,0.0407605731552977,-0.106862399651262,0.0529190471175045,0.508177491465756
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31350,-0.0323943346511249,0.030581685551954,-0.0923344383329547,0.027545769030705,0.289509910999058
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31353,-0.0213655395493605,0.0419836366008496,-0.103653467287026,0.0609223881883048,0.610836187388941
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31353,0.0157592180066127,0.0207865134830064,-0.0249823484200798,0.0565007844333052,0.448387256468625
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31353,-0.0189340471845818,0.0281197927120368,-0.0740488409001739,0.0361807465310103,0.500754809492925
CCND2,G1/S-specific cyclin-D2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31353,0.0259474503749239,0.0483827475715327,-0.0688827348652802,0.120777635615128,0.591770252216279
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20600.Liking for adding salt to foods,33290,-0.0706320772586637,0.046802225041345,-0.1623644383397,0.0211002838223725,0.131291263211642
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20601.Liking for aniseed,33290,-0.0403893873137742,0.0473523985306235,-0.133200088433796,0.0524213138062479,0.393706854522404
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20602.Liking for apple juice,33290,0.0410707351362507,0.0468967753772709,-0.0508469446032003,0.132988414875702,0.381178034154122
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20603.Liking for apples,33290,0.109935046983448,0.0477780519693565,0.016290065123509,0.203580028843386,0.0214160233146325
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20604.Liking for asparagus,33290,-0.00460849536284726,0.0480355085011347,-0.0987580920250713,0.0895411012993768,0.923570784158348
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20605.Liking for aubergine,33290,0.0409767679339558,0.0471256322885371,-0.0513894713515769,0.133343007219489,0.384583903199768
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20606.Liking for avocados,33290,-0.00379688546296297,0.0478556459209376,-0.0975939514680007,0.0900001805420747,0.936763568544365
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20607.Liking for bacon,33290,0.00226935634650159,0.0473694080725225,-0.0905746834756425,0.0951133961686457,0.961790869449158
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20608.Liking for baked or steamed fish,33290,0.0703880455989047,0.0476217878917562,-0.0229506586689375,0.163726749866747,0.139424105099603
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20609.Liking for bananas,33290,0.020253100254105,0.0485082704286775,-0.0748231097861028,0.115329310294313,0.676308710775693
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33290,-0.0348333920252364,0.0474330895291116,-0.127802247502295,0.0581354634518223,0.462742132648286
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20611.Liking for beef steak,33290,-0.0476065005576725,0.0473969496880435,-0.140504521946238,0.0452915208308927,0.315201437849453
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20612.Liking for beetroot,33290,0.101973661425764,0.0477313468084789,0.00842022168114501,0.195527101170382,0.0326718130618885
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20613.Liking for bell pepper,33290,-0.042224206522709,0.0475607043071689,-0.13544318696476,0.050994773919342,0.374673120067202
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20614.Liking for bicycling,33290,0.00185409297629361,0.0471199614369036,-0.0905010314400375,0.0942092173926247,0.968613488383608
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20615.Liking for biscuits,33290,-0.0283849574219521,0.0476411336972628,-0.121761579468587,0.0649916646246829,0.551317968356611
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20616.Liking for bitter foods,33290,0.00782729194715582,0.0474023083118101,-0.0850812323439919,0.100735816238304,0.868849374785554
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20617.Liking for bitter or ale,33290,-0.0133704179427487,0.0481310899248884,-0.10770735419553,0.0809665183100327,0.781178348290434
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20618.Liking for black olives,33290,0.0491140998876067,0.0472424480505063,-0.0434810982913858,0.141709298066599,0.298544085413212
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20619.Liking for black pepper,33290,0.0288517203861864,0.0476727386202264,-0.0645868473094573,0.12229028808183,0.545058199035385
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20620.Liking for blue cheese,33290,0.0230325681715394,0.0470611901235286,-0.0692073644705765,0.115272500813655,0.624557571416357
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20621.Liking for bolognese sauce,33290,-0.0808239787785136,0.0476317963511405,-0.174182299626749,0.0125343420697217,0.0897581942485936
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20622.Liking for broad beans,33290,0.0430539999933417,0.0472455990695941,-0.0495473741830629,0.135655374169746,0.362170837704563
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20623.Liking for broccoli,33290,0.134197998253359,0.0485213065202297,0.0390962374737086,0.229299759033009,0.00569019509043603
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20624.Liking for brown rice,33290,0.0354397045167239,0.0472663597828334,-0.0572023606576296,0.128081769691077,0.453401691417888
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20625.Liking for brussel sprouts,33290,0.0155254968953065,0.0473932745962417,-0.0773653213133272,0.10841631510394,0.743230014922597
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20626.Liking for burgers (meat),33290,-0.0185606964336363,0.047013673676567,-0.110707496839708,0.073586103972435,0.693004172291293
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20627.Liking for burn of spicy foods,33290,0.0539034650597619,0.046762417817273,-0.0377508738620932,0.145557803981617,0.249059047503934
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20628.Liking for butter on bread,33290,0.0200358954011773,0.0479951600380972,-0.0740346182734932,0.114106409075848,0.6763539896038
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20629.Liking for butternut squash,33290,0.0251294881939102,0.0472302831903984,-0.0674418668592707,0.117700843247091,0.594694879252886
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20630.Liking for cabbage,33290,0.104143539140869,0.0475609808959177,0.0109240165848703,0.197363061696868,0.0285715704130063
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20631.Liking for cake,33290,0.11466872584157,0.0472644995356589,0.0220303067516786,0.207307144931462,0.0152804241255224
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20632.Liking for cake icing,33290,-0.00229477728895423,0.0467498402674419,-0.0939244642131404,0.0893349096352319,0.960851551497971
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20633.Liking for capers,33290,0.0518179273291837,0.0466837879344632,-0.0396822970223642,0.143318151680732,0.267037300852372
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20634.Liking for cauliflower,33290,0.0387942120935894,0.04789348420361,-0.0550770169454861,0.132665441132665,0.417954755769067
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20635.Liking for cereal or granola bar,33290,0.0335117485602207,0.0472842040469661,-0.0591652913718328,0.126188788492274,0.478509388609479
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20636.Liking for cheesecake,33290,0.0783628069579723,0.0468756344243112,-0.0135134365136776,0.170239050429622,0.0946132994695457
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20637.Liking for cherries,33290,-0.0177288123844397,0.0490487110106607,-0.113864285965335,0.0784066611964552,0.717768807770539
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20638.Liking for chicken,33290,-0.00678587192894895,0.0495554734666286,-0.103914599923541,0.090342856065643,0.891085208444976
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20639.Liking for chilli pepper,33290,-0.00878141173363845,0.0469281519228115,-0.100760589502349,0.0831977660350722,0.851566969032492
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20640.Liking for chips or french fries,33290,-0.024012960233961,0.0472478412482889,-0.116618729080607,0.0685928086126852,0.611301135931822
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20641.Liking for cigarette smoking,33290,-0.0901788459221323,0.0748234159967701,-0.236832741275802,0.056475049431537,0.228147786152346
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20642.Liking for cod,33290,0.0579743631982392,0.0481921391597061,-0.0364822295547847,0.152430955951263,0.229012816093687
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20643.Liking for coffee with sugar,33290,0.0276144863902794,0.0515662763558982,-0.0734554152672811,0.12868438804784,0.592306805517286
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20644.Liking for coffee without sugar,33290,0.0997026123961171,0.0479684116230104,0.00568452561501669,0.193720699177217,0.0376898160002885
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20645.Liking for coriander,33290,0.00901531357341258,0.0474233193558944,-0.0839343923641405,0.101965019510966,0.849232543260767
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20646.Liking for corn flakes,33290,-0.0191796506803388,0.0471367613126451,-0.111567702853123,0.0732084014924455,0.684095315248442
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20647.Liking for cream,33290,0.0266742007201379,0.0468350475274921,-0.0651224924337467,0.118470893874022,0.569006676629429
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20648.Liking for croissant,33290,0.0203181731953464,0.0473031298204665,-0.0723959612527679,0.113032307643461,0.667546469007243
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20649.Liking for cucumber,33290,0.0295071121590698,0.0474952474766091,-0.063583572895084,0.122597797213224,0.534440624737744
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20650.Liking for curry,33290,-0.0178820732017969,0.0477006202229664,-0.111375288838811,0.0756111424352173,0.707757143649514
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20651.Liking for dairy products,33290,0.0777232208595644,0.0479340418467046,-0.0162275011599765,0.171673942879105,0.10495208634099
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20652.Liking for dark chocolate,33290,-0.087229542279552,0.0475388749465861,-0.180405737174861,0.00594665261575669,0.0665505829532234
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20653.Liking for diet fizzy drinks,33290,-0.0128425061650324,0.0481787239600036,-0.10727280512664,0.0815877927965747,0.789814022376808
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20654.Liking for dried fruit,33290,0.06204733720182,0.0474666868713534,-0.0309873690660327,0.155082043469673,0.191184680270156
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20655.Liking for eggs,33290,0.0208399073637844,0.0487877752563116,-0.0747841321385863,0.116463946866155,0.669276716055511
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20656.Liking for exercising alone,33290,-0.0261987136309418,0.0470869913518365,-0.118489216680541,0.0660917894186579,0.577957742196565
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20657.Liking for exercising with others,33290,0.0461344249804156,0.0468688976119371,-0.045728614338981,0.137997464299812,0.32497894960893
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20658.Liking for extra virgin olive oil,33290,-0.0112252058848437,0.0483169066243071,-0.105926342868486,0.0834759310987983,0.816290955377045
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20659.Liking for fatty foods,33290,0.0101334224937869,0.0470537575218315,-0.0820919422490028,0.102358787236577,0.829492553562614
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20660.Liking for fresh tomatoes,33290,0.0684603646201254,0.0505361979428753,-0.0305905833479103,0.167511312588161,0.175552093634559
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20661.Liking for fried chicken,33290,0.0140525733142372,0.0468232730595681,-0.0777210418825163,0.105826188510991,0.764092692145043
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20662.Liking for fried or battered fish,33290,0.0477395720113493,0.0472697672342892,-0.0449091717678575,0.140388315790556,0.312550549335117
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20663.Liking for fruit,33290,0.0636073994671994,0.0517261861503695,-0.0377759253875249,0.164990724321924,0.218842287149723
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20664.Liking for garlic,33290,-0.0181020846506371,0.047962821744814,-0.112109215270473,0.0759050459691984,0.705870682224911
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20665.Liking for gherkins,33290,-0.0080324816073207,0.0465597533303361,-0.0992895981347794,0.083224634920138,0.863032564046832
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20666.Liking for globe artichoke,33290,-0.0120240713681137,0.047316831336985,-0.104765060788604,0.0807169180523769,0.7994097342151
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20667.Liking for goat's cheese,33290,-0.00607491429231989,0.0470885699025537,-0.0983685113013251,0.0862186827166853,0.897352189445652
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20668.Liking for going to a cafe,33290,0.00648447211814919,0.0475647453263878,-0.0867424287215709,0.0997113729578693,0.891563813769724
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20669.Liking for going to the gym,33290,0.00931796498335646,0.0468386181287319,-0.082485726548958,0.101121656515671,0.842315804534303
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20670.Liking for going to the pub,33290,-0.0459167517772023,0.0468082741484289,-0.137660969108123,0.0458274655537184,0.326640742318932
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20671.Liking for grapefruit,33290,0.070858419243496,0.0467380111963178,-0.0207480827012869,0.162464921188279,0.129533458553529
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20672.Liking for green olives,33290,0.0244691659650228,0.0473497254295593,-0.0683362958769135,0.117274627806959,0.605325193205378
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20673.Liking for haddock,33290,0.0559998937834482,0.0478813653126126,-0.0378475822292725,0.149847369796169,0.242209653777673
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20674.Liking for ham,33290,-0.00192367105441936,0.047382017802895,-0.0947924259480936,0.0909450838392549,0.967616298442819
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20675.Liking for hard cheese,33290,0.0625724716084217,0.0479873412162245,-0.0314827171753783,0.156627660392222,0.192286908898696
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20676.Liking for herring,33290,0.112568496182055,0.047022497608764,0.0204044008688778,0.204732591495233,0.0166884347755826
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20677.Liking for honey,33290,0.0554318758091407,0.0468917386883612,-0.0364759320200473,0.147339683638329,0.23718611733132
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20678.Liking for horseradish or wasabi,33290,-9.6187608395905e-06,0.0468849149601801,-0.0919040520827926,0.0918848145611134,0.999836312872381
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20679.Liking for ice cream,33290,0.0104511521260403,0.0473405489782672,-0.0823363238713634,0.103238628123444,0.825279940755114
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20680.Liking for jam,33290,0.00451077711254122,0.0470260997537148,-0.0876603784047399,0.0966819326298223,0.923585582423354
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20681.Liking for kiwi fruit,33290,0.0192170525680933,0.0470407726672218,-0.0729828618596613,0.111416966995848,0.682901919977941
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20682.Liking for lager,33290,-0.0694705321888117,0.046962270653133,-0.161516582668952,0.0225755182913291,0.139097881658884
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20683.Liking for lamb,33290,-0.0516285764119737,0.0476307862626468,-0.144984917486761,0.0417277646628139,0.278422288485579
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20684.Liking for lemons,33290,-0.0138860204227036,0.0472522455586608,-0.106500421717679,0.0787283808722716,0.768863667826351
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20685.Liking for lentils or beans,33290,0.0136538720469316,0.0476605035811963,-0.0797607149722132,0.107068459066076,0.774515347199742
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20686.Liking for liver,33290,0.0228381001508342,0.0475525618248944,-0.0703649210259589,0.116041121327627,0.631046101164286
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20687.Liking for mackerel,33290,0.113834421097399,0.0477112547924835,0.0203203617041311,0.207348480490667,0.0170568821384857
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20688.Liking for marzipan,33290,0.0193445858085475,0.046888421950158,-0.0725567212137622,0.111245892830857,0.679933736408919
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20689.Liking for mayonnaise,33290,-0.0987753294840545,0.0471385384897021,-0.191166864923871,-0.00638379404423839,0.0361597458666287
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20690.Liking for melon,33290,-0.0583457640843117,0.0483800301051641,-0.153170623090433,0.03647909492181,0.227852177421148
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20691.Liking for milk chocolate,33290,0.0671561012631874,0.04744367219234,-0.025833496233799,0.160145698760174,0.156957577468223
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20692.Liking for mushrooms,33290,0.00298688275866584,0.0487956146471475,-0.0926525219497432,0.0986262874670749,0.951191580173282
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20694.Liking for orange juice,33290,0.029290753614133,0.0471038899911424,-0.0630328707685062,0.121614377996772,0.534066726538699
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20695.Liking for oranges,33290,0.0378956557902021,0.0481736263411426,-0.0565246518384373,0.132315963418842,0.431508116165068
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20696.Liking for pasta,33290,0.0112274720481844,0.0479929844052001,-0.0828387773860079,0.105293721482377,0.815036751142072
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20697.Liking for pears,33290,0.0512104771273927,0.0481152651785511,-0.0430954426225675,0.145516396877353,0.287206915522857
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20698.Liking for pizza,33290,0.0344470681519613,0.047134142165564,-0.0579358504925443,0.126829986796467,0.464900872990916
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20699.Liking for plain yogurt,33290,0.0307435930084184,0.0475342858161719,-0.0624236071912786,0.123910793208115,0.517798705955929
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20700.Liking for plums,33290,0.0816307274169488,0.0479189270104915,-0.0122903695236145,0.175551824357512,0.0885042593534317
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20701.Liking for pollock,33290,0.0296438065361203,0.0471651845405816,-0.0627999551634197,0.12208756823566,0.529684906812569
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20702.Liking for pork chop,33290,0.0285915703230593,0.0471559785797281,-0.0638341476932078,0.121017288339326,0.544317488967913
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20703.Liking for porridge,33290,0.110862127583928,0.0476232913044889,0.0175204766271298,0.204203778540726,0.019938626183824
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20704.Liking for potato crisps,33290,-0.0136742907652884,0.0474121222393661,-0.106602050354446,0.0792534688238692,0.773036666468637
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20705.Liking for potatoes,33290,-0.00242990737841918,0.0479149159159108,-0.0963431425736043,0.091483327816766,0.959555321618574
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20706.Liking for prawns,33290,0.0401487300864534,0.0477860298051411,-0.0535118883316231,0.13380934850453,0.400830392244333
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20707.Liking for raw carrots,33290,0.0183534165764776,0.0478901334285724,-0.0755112449435242,0.112218078096479,0.701550440754466
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20708.Liking for red meat,33290,-0.044918237918973,0.0473946898797721,-0.137811830083326,0.0479753542453803,0.343281902282565
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20709.Liking for red wine,33290,-0.0202804804768788,0.0473459560121539,-0.113078554260701,0.0725175933069428,0.66840857047889
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33290,-0.0325574359383438,0.048699522935774,-0.128008500892461,0.0628936290157733,0.503807212435873
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20711.Liking for roast chicken,33290,0.0101368834062647,0.0496188621427552,-0.0871160863935355,0.107389853206065,0.838127422010517
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20712.Liking for salad dressing,33290,-0.0568885659523983,0.0467502932391639,-0.148519140701159,0.034742008796363,0.223687936005607
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20713.Liking for salad leaves,33290,0.0406747150994125,0.0485843389880582,-0.0545505893171816,0.135900019516007,0.402502475508449
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20714.Liking for salami,33290,0.0182864167094675,0.0470656046088363,-0.0739621683238516,0.110535001742787,0.697632364535834
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20715.Liking for salmon,33290,0.0630054696832459,0.0491931826733724,-0.0334131683565641,0.159424107723056,0.200303728147394
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20716.Liking for salty foods,33290,-0.0461131829770082,0.0467460544860625,-0.137735449769691,0.0455090838156744,0.323932032876864
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20717.Liking for salty pretzels,33290,-0.0190978012269174,0.0469936736569748,-0.111205401594588,0.0730097991407532,0.684464637423042
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20718.Liking for sardines,33290,0.0554031297135529,0.0469009000490501,-0.0365226343825853,0.147328893809691,0.237521036624868
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20719.Liking for sausages (meat),33290,-0.0167181802957149,0.0471998459750992,-0.109229878406909,0.0757935178154796,0.723197012381493
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20720.Liking for savoury biscuits,33290,-0.042162494422552,0.0474567298067139,-0.135177684843711,0.0508526959986072,0.374326375797732
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33290,-0.0351973400596824,0.0467530749123447,-0.126833366887878,0.0564386867685133,0.451568025054141
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20722.Liking for skimmed milk,33290,0.0334321593312762,0.0470295882048408,-0.0587458335502117,0.125610152212764,0.477179286743306
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20723.Liking for smoked fish,33290,0.00321287773833461,0.047516184062286,-0.0899188430237458,0.0963445985004151,0.946092360631146
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20724.Liking for soft cheese,33290,-0.00977806415598858,0.0473147564541824,-0.102514986806186,0.0829588584942089,0.836279920724072
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20725.Liking for soy sauce,33290,0.00848718210498191,0.0473342723333178,-0.0842879916683209,0.101262355878285,0.857703563128439
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20726.Liking for soya milk,33290,0.0424340391576207,0.0472341354491802,-0.0501448663227725,0.135012944638014,0.369007798506323
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20727.Liking for spicy foods,33290,0.0249226030778634,0.0473938251541841,-0.0679692942243375,0.117814500380064,0.598996596638878
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20728.Liking for spinach,33290,-0.0340233179759331,0.0475519628042934,-0.127225165072348,0.059178529120482,0.474319319763051
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20729.Liking for spirits,33290,-0.0622395580757755,0.0467916733740072,-0.15395123788883,0.0294721217372785,0.183503772584591
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20730.Liking for strawberries,33290,-0.0290627379728975,0.0512760347919435,-0.129563766165107,0.0714382902193117,0.570870444938519
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33290,-0.0154656660448223,0.0481785217310215,-0.109895568637624,0.0789642365479798,0.74821183986502
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20732.Liking for sweet foods,33290,0.0267803938192173,0.0468228448939824,-0.0649923821729883,0.118553169811423,0.567368515774821
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20733.Liking for taking the stairs,33290,0.0196819875795825,0.0485307020160814,-0.0754381883719371,0.114802163531102,0.685077010654515
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20734.Liking for tea with sugar,33290,0.04229001871506,0.0572051075592677,-0.0698319921011048,0.154412029531225,0.459761493141624
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20735.Liking for tea without sugar,33290,0.0586813197253624,0.0492289254238685,-0.0378073741054199,0.155170013556145,0.233287760775451
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20736.Liking for tomato ketchup,33290,-0.0811422486177977,0.0470077748218122,-0.173277487268549,0.0109929900329541,0.084354065670012
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20737.Liking for tinned tuna,33290,0.0237162884790475,0.0474759420837633,-0.0693365580051286,0.116769134963224,0.617408360833481
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20738.Liking for turnip (white),33290,0.0207086973034187,0.0470144863325826,-0.0714396959084432,0.112857090515281,0.659603353010966
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20739.Liking for vegetables,33290,0.113966117251319,0.0521936902928142,0.0116664842774031,0.216265750225235,0.0290219114054852
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20740.Liking for vinegar,33290,0.0154788153571668,0.0471068603747669,-0.0768506309773764,0.10780826169171,0.742473358397707
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20741.Liking for watching television,33290,-0.0580187474331215,0.0475367907841413,-0.151190857370038,0.0351533625037954,0.222305185613275
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20742.Liking for whisky,33290,-0.0786831531705394,0.048720300604699,-0.17417494235575,0.0168086360146707,0.106344769856232
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20743.Liking for white bread,33290,0.0297064722325926,0.0466611376637146,-0.0617493575882879,0.121162302053473,0.524373078915387
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20744.Liking for white rice,33290,-0.0739876332508763,0.0473473948633751,-0.166788527183091,0.0188132606813388,0.118167402403924
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20745.Liking for white wine,33290,0.070548779069057,0.04684667415112,-0.0212707022671383,0.162368260405252,0.13211337086992
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33290,0.0272455298188731,0.0476809479615622,-0.0662091281857887,0.120700187823535,0.56773311850042
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20747.Liking for whole milk,33290,0.0941068156311973,0.0467754419522432,0.00242694940480055,0.185786681857594,0.0442604640475603
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20748.Liking for wholemeal bread,33290,0.0552568489933711,0.0490855962159012,-0.0409509195897952,0.151464617576537,0.260310906278117
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20749.Liking for working up a sweat,33290,0.0309174017815283,0.047282707612605,-0.0617567051391775,0.123591508702234,0.51320255991969
CCND2,G1/S-specific cyclin-D2,Physical measures,X21001.Body mass index (BMI),47891,0.0273215682004553,0.0103414413767995,0.00705234310192816,0.0475907932989824,0.00824836764202307
CCND2,G1/S-specific cyclin-D2,Physical measures,X21002.Weight,47909,-0.00533179583917165,0.00606591040643114,-0.0172209802357767,0.00655738855743338,0.379422519145751
CCND2,G1/S-specific cyclin-D2,Physical measures,X21021.Pulse wave Arterial Stiffness index,31799,-0.00164443003685253,0.00465048915593386,-0.0107593887824829,0.00747052870877784,0.723645312349025
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32822,0.0130539367698701,0.0505857042640699,-0.0860940435877068,0.112201917127447,0.796369735293816
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32823,-0.112050436441527,0.0532463778694813,-0.21641333706571,-0.00768753581734347,0.0353733846885477
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32823,0.0585996889919784,0.0524895001338198,-0.0442797312703085,0.161479109254265,0.264277540653712
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21040.Satisfaction with bowel habits,32795,0.00793960011836978,0.0484938764374771,-0.0871083976990853,0.102987597935825,0.869952313564703
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32796,-0.0234887378589964,0.0514142921278924,-0.124260750429666,0.0772832747116728,0.647788323652337
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21042.Greatest number of times bowels opened per day,32787,0.0287948207336049,0.0526705497619207,-0.0744394567997596,0.132029098266969,0.584600722251635
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21043.Least number of times bowels opened per week,32734,0.0600373467471098,0.0518367369339143,-0.0415626576433622,0.161637351137582,0.246813301661722
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21044.Average number of times bowels opened per day,32769,0.0979860607100329,0.0581709264693493,-0.0160289551698919,0.212001076589958,0.0921296492118261
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32827,-0.0369571756984001,0.0525600707347298,-0.13997491433847,0.0660605629416703,0.481985725176388
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32821,-0.0156429326984254,0.052672217042421,-0.11888047810157,0.0875946127047197,0.7664837680896
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,29098,-0.0668668652050752,0.0785351571968118,-0.220795773310826,0.0870620429006759,0.394571751083134
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32824,-0.0249934342335482,0.0559570669393631,-0.1346692854347,0.0846824169676035,0.655135865753933
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32822,0.00597065010600801,0.0790825997021669,-0.149031245310239,0.160972545522255,0.939819449815648
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32825,-0.0140856745291592,0.0628688015317887,-0.137308525531465,0.109137176473147,0.822724499445933
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32823,0.121009062134525,0.153030341485246,-0.178930407176558,0.420948531445608,0.429109598004869
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32826,-0.0386775190734969,0.0595642533989401,-0.155423455735419,0.0780684175884256,0.516134547264026
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32825,-0.118671935481792,0.0622057497471576,-0.24059520498622,0.00325133402263728,0.0564577097498198
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32607,0.0317821999004768,0.0554111975223417,-0.076823747243313,0.140388147044267,0.566273575246846
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32825,-0.00876196878537948,0.05484005013041,-0.116248467040983,0.0987245294702241,0.873063357680679
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32826,-0.0159508784484023,0.0757375323679823,-0.164396441889648,0.132494684992843,0.833198489098118
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32825,0.0248959293360503,0.0526667609168281,-0.0783309220609328,0.128122780733033,0.636433973796578
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32825,-0.00813560913496291,0.0525400024589974,-0.111114013954598,0.094842795684672,0.876946213295158
CCND2,G1/S-specific cyclin-D2,Working and living environment,X21100.Water hardness (USGS classification),47693,0.0562752126359008,0.0321758959438539,-0.00678954341405281,0.119339968685855,0.0803061995791251
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2139.Age first had sexual intercourse,45338,0.00446272722983582,0.00279604287455318,-0.0010175168042884,0.00994297126396005,0.110484119218201
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2149.Lifetime number of sexual partners,43606,-0.0633014308067516,0.0363209299638297,-0.134490453535858,0.00788759192235459,0.0813778018194973
CCND2,G1/S-specific cyclin-D2,Physical activities,X22032.IPAQ activity group,43586,0.0783803210796507,0.0347779637035471,0.0102155122206984,0.146545129938603,0.0242237630627994
CCND2,G1/S-specific cyclin-D2,Physical activities,X22033.Summed days activity,44087,0.00660840962837116,0.00269227433899145,0.00133155192394792,0.0118852673327944,0.0141131893624154
CCND2,G1/S-specific cyclin-D2,Physical activities,X22034.Summed minutes activity,43586,0.00582819593323432,0.00274767617108129,0.000442750637914982,0.0112136412285537,0.0339227633639462
CCND2,G1/S-specific cyclin-D2,Physical activities,X22037.MET minutes per week for walking,42917,0.00499977761239215,0.00271441151881745,-0.000320468964490051,0.0103200241892744,0.0654997534254921
CCND2,G1/S-specific cyclin-D2,Physical activities,X22038.MET minutes per week for moderate activity,43586,0.00849159590815713,0.00282087620471301,0.00296267854691964,0.0140205132693946,0.00261346512988752
CCND2,G1/S-specific cyclin-D2,Physical activities,X22039.MET minutes per week for vigorous activity,43586,0.0377067612553316,0.0345662837708444,-0.0300431549355235,0.105456677446187,0.275350553260404
CCND2,G1/S-specific cyclin-D2,Physical activities,X22040.Summed MET minutes per week for all activity,42917,0.00765723822675871,0.00278903379283358,0.00219073199280489,0.0131237444607125,0.00604789722911131
CCND2,G1/S-specific cyclin-D2,Eye measures,X2217.Age started wearing glasses or contact lenses,43101,0.00213028526262609,0.00321353538289902,-0.00416824408785599,0.00842881461310817,0.507396033731348
CCND2,G1/S-specific cyclin-D2,Working and living environment,X22501.Year ended full time education,30015,0.001204407392166,0.0141155262510707,-0.0264620240599325,0.0288708388442645,0.932005785578864
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X22506.Tobacco smoking,29973,-0.0696393820964321,0.127121520663461,-0.318797562596816,0.179518798403952,0.583837291504705
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46270,0.0602251798441143,0.0713515650848409,-0.079623887722174,0.200074247410403,0.398643496057396
CCND2,G1/S-specific cyclin-D2,Physical measures,X23098.Weight,47586,-0.00440371317139105,0.0061085121915277,-0.0163763970667853,0.00756897072400325,0.470969409464831
CCND2,G1/S-specific cyclin-D2,Physical measures,X23099.Body fat percentage,47564,-0.0178096374057819,0.00590406426503428,-0.0293816033652491,-0.00623767144631475,0.00255978356870103
CCND2,G1/S-specific cyclin-D2,Physical measures,X23100.Whole body fat mass,47534,-0.0103821786114699,0.0056174249272771,-0.021392331468933,0.000627974245993198,0.0645844921460983
CCND2,G1/S-specific cyclin-D2,Physical measures,X23101.Whole body fat-free mass,47583,0.00571535819411024,0.00521584278208618,-0.00450769365877868,0.0159384100469992,0.273191055203799
CCND2,G1/S-specific cyclin-D2,Physical measures,X23102.Whole body water mass,47586,0.00687160508354986,0.00521608468664951,-0.00335192090228317,0.0170951310693829,0.187721469875431
CCND2,G1/S-specific cyclin-D2,Physical measures,X23104.Body mass index (BMI),47586,0.0275706950383341,0.0104374246624609,0.00711334269991068,0.0480280473767575,0.00825883650686443
CCND2,G1/S-specific cyclin-D2,Physical measures,X23105.Basal metabolic rate,47584,0.00422532198708205,0.0055903947383379,-0.00673185170006023,0.0151824956742243,0.449765718293726
CCND2,G1/S-specific cyclin-D2,Physical measures,X23106.Impedance of whole body,47583,-0.0171847779654393,0.00427264280755187,-0.025559157868241,-0.00881039806263763,5.78726687739693e-05
CCND2,G1/S-specific cyclin-D2,Physical measures,X23107.Impedance of leg (right),47583,-0.013732804515962,0.00352722312595489,-0.0206461618428336,-0.00681944718909037,9.91294518403059e-05
CCND2,G1/S-specific cyclin-D2,Physical measures,X23108.Impedance of leg (left),47582,-0.0127912329516566,0.00349287626241926,-0.0196372704259984,-0.00594519547731487,0.000250707984363776
CCND2,G1/S-specific cyclin-D2,Physical measures,X23109.Impedance of arm (right),47577,-0.0141983486765239,0.00429315033486839,-0.0226129233328659,-0.00578377402018183,0.000943703649258243
CCND2,G1/S-specific cyclin-D2,Physical measures,X23110.Impedance of arm (left),47581,-0.0143233751142926,0.0042862384867811,-0.0227244025483835,-0.00592234768020161,0.000833919593032406
CCND2,G1/S-specific cyclin-D2,Physical measures,X23111.Leg fat percentage (right),47582,-0.0219438894602567,0.00728320913556178,-0.0362189793659578,-0.0076687995545556,0.00259000925880177
CCND2,G1/S-specific cyclin-D2,Physical measures,X23112.Leg fat mass (right),47581,-0.0160681025191877,0.00753996585838664,-0.0308464356016255,-0.00128976943674989,0.0330946389180162
CCND2,G1/S-specific cyclin-D2,Physical measures,X23113.Leg fat-free mass (right),47581,0.00617162121451895,0.00560492652680428,-0.00481403477801745,0.0171572772070553,0.270861467010639
CCND2,G1/S-specific cyclin-D2,Physical measures,X23114.Leg predicted mass (right),47580,0.00650504984770881,0.00563076053681449,-0.00453124080444759,0.0175413404998652,0.247991432750159
CCND2,G1/S-specific cyclin-D2,Physical measures,X23115.Leg fat percentage (left),47579,-0.0204442066611193,0.0075274231731524,-0.035197956080498,-0.00569045724174061,0.00661310709966892
CCND2,G1/S-specific cyclin-D2,Physical measures,X23116.Leg fat mass (left),47579,-0.0117774921587732,0.00784380895357215,-0.0271513577077746,0.0035963733902282,0.133239169474255
CCND2,G1/S-specific cyclin-D2,Physical measures,X23117.Leg fat-free mass (left),47577,0.00526070123851821,0.00581282707887882,-0.00613243983608427,0.0166538423131207,0.365466128863475
CCND2,G1/S-specific cyclin-D2,Physical measures,X23118.Leg predicted mass (left),47576,0.00494108599822231,0.00583587510029354,-0.00649722919835304,0.0163794011947977,0.397185179687489
CCND2,G1/S-specific cyclin-D2,Physical measures,X23119.Arm fat percentage (right),47576,-0.0107063642168874,0.00652629150999894,-0.0234978955764854,0.0020851671427105,0.100915051223766
CCND2,G1/S-specific cyclin-D2,Physical measures,X23120.Arm fat mass (right),47575,-0.00213646402490941,0.0063661189412734,-0.0146140571498053,0.0103411290999865,0.737176143327727
CCND2,G1/S-specific cyclin-D2,Physical measures,X23121.Arm fat-free mass (right),47574,0.00708401344595126,0.0052253555856703,-0.00315768350196253,0.0173257103938651,0.175207618007634
CCND2,G1/S-specific cyclin-D2,Physical measures,X23122.Arm predicted mass (right),47573,0.00939784255374049,0.00522549498322104,-0.000844127613372747,0.0196398127208537,0.0721168896883516
CCND2,G1/S-specific cyclin-D2,Physical measures,X23123.Arm fat percentage (left),47570,-0.0115184454611382,0.00666683820533958,-0.0245854483436038,0.00154855742132733,0.084051033717449
CCND2,G1/S-specific cyclin-D2,Physical measures,X23124.Arm fat mass (left),47570,-0.0012729170592473,0.00633714412104195,-0.0136937195364895,0.0111478854179949,0.840805043750918
CCND2,G1/S-specific cyclin-D2,Physical measures,X23125.Arm fat-free mass (left),47566,0.00864764933216853,0.00530608670049881,-0.00175228060080914,0.0190475792651462,0.103165458222718
CCND2,G1/S-specific cyclin-D2,Physical measures,X23126.Arm predicted mass (left),47565,0.00983185515131609,0.00533461259912586,-0.000623985542970589,0.0202876958456028,0.0653369954763248
CCND2,G1/S-specific cyclin-D2,Physical measures,X23127.Trunk fat percentage,47563,-0.0102747565662252,0.00423197860837793,-0.018569434638646,-0.00198007849380449,0.0151945596573017
CCND2,G1/S-specific cyclin-D2,Physical measures,X23128.Trunk fat mass,47559,-0.0100690350029832,0.00461880604939782,-0.0191218948598029,-0.00101617514616348,0.0292666608508933
CCND2,G1/S-specific cyclin-D2,Physical measures,X23129.Trunk fat-free mass,47555,0.00352192746426303,0.00475114947374744,-0.00579032550428195,0.012834180432808,0.45853162118905
CCND2,G1/S-specific cyclin-D2,Physical measures,X23130.Trunk predicted mass,47553,0.00304195660780717,0.00474338825066233,-0.00625508436349099,0.0123389975791053,0.521331017756404
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23400.Total Cholesterol,37169,0.0211338155124042,0.00358893619129111,0.0140995005774736,0.0281681304473348,3.98870842704487e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37169,0.0195121063541031,0.00348061086303656,0.0126901090625514,0.0263341036456547,2.11242114583995e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37169,0.0211615778118729,0.00349378198682929,0.0143137651176875,0.0280093905060583,1.42487319852463e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23403.VLDL Cholesterol,37169,0.0174331503776552,0.00343952844935723,0.0106916746169151,0.0241746261383954,4.0640563050904e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23404.Clinical LDL Cholesterol,37169,0.018118687762307,0.00347804467834806,0.0113017201927449,0.0249356553318692,1.92232608566183e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23405.LDL Cholesterol,37169,0.0172194267335701,0.00344988781483014,0.010457646616503,0.0239812068506372,6.07324437158369e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23406.HDL Cholesterol,37169,0.009894279565598,0.00395147680511091,0.00214938502758061,0.0176391741036154,0.0122935928539833
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23407.Total Triglycerides,37169,0.00834858304896312,0.00353648562337671,0.00141707122714476,0.0152800948707815,0.0182547964112692
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23408.Triglycerides in VLDL,37169,0.00798396358589901,0.00359208960761824,0.000943467954967265,0.0150244592168308,0.0262560420349141
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23409.Triglycerides in LDL,37169,0.00955759472454983,0.00337779421331863,0.00293711806644531,0.0161780713826543,0.00466851264787791
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23410.Triglycerides in HDL,37169,0.00619716034543661,0.00334378073775698,-0.000356649900567064,0.0127509705914403,0.0638558534620029
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37169,0.0204972819671627,0.00355507278851031,0.0135293393016825,0.0274652246326429,8.31526795084026e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23412.Phospholipids in VLDL,37169,0.0144251571022716,0.00347759328015836,0.00760907427316123,0.021241239931382,3.37432339816065e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23413.Phospholipids in LDL,37169,0.0174267758090864,0.00345210023198474,0.0106606593543964,0.0241928922637765,4.51964596439307e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23414.Phospholipids in HDL,37169,0.0101084770318415,0.00370644753433506,0.00284383986454483,0.0173731141991382,0.00639447746441128
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23415.Total Esterified Cholesterol,37169,0.0208253945675648,0.00360319546194071,0.013763131462161,0.0278876576729686,7.6510392412014e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37169,0.0183498893062966,0.00344024457488395,0.0116070099395241,0.0250927686730692,9.77037845039206e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37169,0.0170880540058114,0.00343664732167523,0.0103522252553279,0.0238238827562948,6.69862692562849e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37169,0.00856365406931374,0.00394301552759445,0.000835343635228612,0.0162919645033989,0.029884275647148
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23419.Total Free Cholesterol,37169,0.0214071885868399,0.00355048490295636,0.0144482381770454,0.0283661389966344,1.68956984809259e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23420.Free Cholesterol in VLDL,37169,0.0158009702389693,0.00345845269979868,0.00902240294736385,0.0225795375305747,4.94938386774998e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23421.Free Cholesterol in LDL,37169,0.0169904429983229,0.00349200159798948,0.0101461198662635,0.0238347661303823,1.15457286278756e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23422.Free Cholesterol in HDL,37169,0.0132664491076537,0.00391702513294707,0.00558907984707747,0.02094381836823,0.000708998791928451
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37169,0.019914772549363,0.0034604170479734,0.0131323551353351,0.0266971899633908,8.85402605109091e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23424.Total Lipids in VLDL,37169,0.0129576989808681,0.00351100095913598,0.0060761371009616,0.0198392608607747,0.000224618718102934
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23425.Total Lipids in LDL,37169,0.017316496572961,0.00344579311834741,0.0105627420610001,0.0240702510849219,5.08900558446474e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23426.Total Lipids in HDL,37169,0.0105673395033846,0.00378991237135195,0.00313911125553478,0.0179955677512344,0.00530638115918948
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37169,0.0125107280132884,0.00357498407689628,0.00550375922257171,0.0195176968040051,0.000467620734641222
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23428.Concentration of VLDL Particles,37169,0.0154871732656217,0.0034329903727935,0.00875851213494644,0.0222158343962969,6.49898104202445e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23429.Concentration of LDL Particles,37169,0.0179766028328215,0.003450353692359,0.0112139095957979,0.0247392960698451,1.91583499029086e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23430.Concentration of HDL Particles,37169,0.00985012095350873,0.00357488149500831,0.00284335322329244,0.016856888683725,0.00587055278185906
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37169,0.00342793709667138,0.00376754878800322,-0.00395645852781494,0.0108123327211577,0.362913502143653
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23432.Average Diameter for LDL Particles,37169,0.00446900200497863,0.00346150949952091,-0.00231555661408237,0.0112535606240396,0.196706744595886
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23433.Average Diameter for HDL Particles,37169,0.0072973520231027,0.00400375585107004,-0.000550009444994581,0.0151447134912,0.0683823864466973
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23434.Phosphoglycerides,37157,0.0173283750512746,0.00351920752548366,0.0104307283013266,0.0242260218012226,8.5836214604524e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37157,0.000928814465808873,0.00378943575131162,-0.00649847960676191,0.00835610853837966,0.806377929938737
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23436.Total Cholines,37157,0.0184399608860661,0.00357871807742472,0.0114256734543137,0.0254542483178186,2.60478102722803e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23437.Phosphatidylcholines,37157,0.0167581051272986,0.0035695267913939,0.00976183261616656,0.0237543776384306,2.69573389440101e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23438.Sphingomyelins,37156,0.0205238837143901,0.00369154322093745,0.0132884590013527,0.0277593084274275,2.75440673350557e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23439.Apolipoprotein B,37169,0.0186782324359647,0.00346269810146388,0.0118913441570955,0.0254651207148339,7.00351837323061e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23440.Apolipoprotein A1,37169,0.00960565432027785,0.00368385939406115,0.002385289907918,0.0168260187326377,0.0091308515605455
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37169,0.0111625325741439,0.00346117908519582,0.00437862156716014,0.0179464435811277,0.00126247492032085
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23442.Total Fatty Acids,37157,0.0160028338048246,0.00337535665125745,0.00938713476836002,0.0226185328412892,2.14787704312897e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23443.Degree of Unsaturation,37157,-0.00216695721509931,0.00373784221641156,-0.00949312795926596,0.00515921352906735,0.562103292950205
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23444.Omega-3 Fatty Acids,37157,0.00532470773901363,0.00343323859877898,-0.00140443991459317,0.0120538553926204,0.120942608107009
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23445.Omega-6 Fatty Acids,37157,0.0179544373776507,0.00342369574084009,0.0112439937256041,0.0246648810296973,1.59396119948591e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37157,0.0169731270452172,0.00342823663160288,0.0102537832472756,0.0236924708431589,7.47467299587086e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37157,0.0136783830112753,0.00343438376363325,0.00694699083455408,0.0204097751879964,6.84775044639103e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23448.Saturated Fatty Acids,37157,0.0156482223301667,0.00339306288556518,0.00899781907445891,0.0222986255858744,4.02865188428459e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23449.Linoleic Acid,37157,0.018604069854013,0.00344843455128627,0.0118451381334919,0.0253630015745341,6.97235761924621e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23450.Docosahexaenoic Acid,37157,0.00422449833027859,0.00358935136398037,-0.00281063034312293,0.0112596270036801,0.239235280642232
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37157,-0.00330598014800771,0.00347142751855215,-0.0101099780843699,0.00349801778835451,0.340941762025563
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37157,-0.00653530644725637,0.0035422978583512,-0.0134782102496247,0.000407597355111974,0.0650693353973794
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37157,-0.00734961516263714,0.00367802239510888,-0.0145585390570505,-0.000140691268223741,0.045709687103506
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37157,0.00493390939482137,0.00376078983306252,-0.00243723867798116,0.0123050574676239,0.189564932093206
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37157,0.00572180498779097,0.00338606402708034,-0.000914880505286495,0.0123584904808684,0.0910877438941198
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37157,0.00390613926136433,0.00362344647447646,-0.00319581582860954,0.0110080943513382,0.281045434223833
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37157,-0.00678968273250653,0.00362552527181204,-0.0138957122652581,0.000316346800245073,0.0611255920054177
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37157,-0.00616395742992939,0.00375751243545825,-0.0135286818034276,0.00120076694356878,0.100938266503593
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37155,0.00160717834757682,0.00344279472086274,-0.00514069930531415,0.0083550560004678,0.640633630746237
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23460.Alanine,37166,-0.00880336998354192,0.00336058252131667,-0.0153901117253226,-0.00221662824176125,0.00881337853484836
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23461.Glutamine,37129,-0.00316895957191576,0.00333511437751099,-0.0097057837518373,0.00336786460800579,0.342038014746903
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23462.Glycine,37154,-0.000973437901718401,0.00347502014439337,-0.00778447738472941,0.00583760158129261,0.779386430721425
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23463.Histidine,37155,0.00101988443549001,0.00330877658983582,-0.00546531768058821,0.00750508655156822,0.757907503959606
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37158,-0.0017728084251317,0.00353648225956623,-0.0087043136538815,0.0051586968036181,0.616174298687989
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23465.Isoleucine,37168,0.00165088114616317,0.00344519097489738,-0.0051016931646357,0.00840345545696203,0.631815453622868
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23466.Leucine,37169,-0.00282757412225399,0.00355281136375718,-0.00979108439521806,0.00413593615071007,0.426122098438087
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23467.Valine,37158,-0.00195696034817469,0.00352386618613481,-0.00886373807299892,0.00494981737664953,0.578668263389475
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23468.Phenylalanine,37165,0.00368957664180262,0.00333504801403724,-0.00284711746571038,0.0102262707493156,0.268615004379885
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23469.Tyrosine,37155,0.00223558632583072,0.00342470075722655,-0.00447682715833332,0.00894799980999477,0.513907492228479
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23470.Glucose,37149,0.00912028739460394,0.00342641957732407,0.00240450502304876,0.0158360697661591,0.0077828086849448
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23471.Lactate,37147,-0.0101204259769287,0.00336134307632283,-0.0167086584065215,-0.00353219354733599,0.00261025815475726
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23472.Pyruvate,37126,-0.0059386857711905,0.00332242747814764,-0.0124506436283599,0.000573272085978869,0.0738869860210331
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23473.Citrate,37168,0.0098045748591437,0.0033932936040703,0.0031537193951659,0.0164554303231215,0.00386603715705997
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23474.3-Hydroxybutyrate,36961,0.00158073166219161,0.00332306653955666,-0.00493247875533944,0.00809394207972266,0.634307007041208
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23475.Acetate,37159,0.00941038824035112,0.00332644121242646,0.00289056346399527,0.015930213016707,0.00467685842068393
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23476.Acetoacetate,37169,0.00537320979540201,0.00329702165307505,-0.0010889526446251,0.0118353722354291,0.103185144461334
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23477.Acetone,37169,0.00109288559757227,0.00331638494272857,-0.00540722889017573,0.00759300008532027,0.741751816018819
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23478.Creatinine,36832,0.0140036171725939,0.00419533019858443,0.00578076998336837,0.0222264643618194,0.000846498269213683
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23479.Albumin,37168,0.00820555628603173,0.00339773698496352,0.00154599179550323,0.0148651207765602,0.0157483290738559
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23480.Glycoprotein Acetyls,37169,0.0147401425737268,0.00356108854596304,0.00776040902363925,0.0217198761238144,3.5062905428018e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37169,0.00673159474457713,0.00357849740476705,-0.000282260168766276,0.0137454496579205,0.0599769633200632
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37169,0.00730351859555153,0.00359355589141761,0.000260149048373013,0.01434688814273,0.0421336791149043
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37169,0.00600377265419635,0.00359978396924643,-0.00105180392552666,0.0130593492339194,0.0953760404538534
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37169,0.00791574048778678,0.00357250702659342,0.000913626715663672,0.0149178542599099,0.0267262893555178
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37169,0.00893255818385301,0.00357853300190037,0.00191863350012829,0.0159464828675777,0.0125669224490927
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37169,0.00685812063433484,0.00354666224812968,-9.33373719993287e-05,0.013809578640669,0.0531732885885183
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37169,0.00712365200659519,0.00358619422519689,9.47113252092839e-05,0.0141525926879811,0.0470082945207217
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37169,0.00845929989025083,0.00362988547872186,0.00134472435195598,0.0155738754285457,0.019796761035314
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37169,0.00870849300185991,0.00363419279058789,0.00158547513230763,0.0158315108714122,0.016576777308781
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37169,0.00996538742265236,0.00361176625002772,0.00288632557259802,0.0170444492727067,0.00580319751517904
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37169,0.0122264579700166,0.0035571361622259,0.0052544710920538,0.0191984448479793,0.000589638393529827
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37169,0.0132408672351378,0.00352348610551864,0.00633483446832126,0.0201469000019543,0.000172085167977705
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37169,0.0108757317908727,0.00358412811226253,0.00385084069083817,0.0179006228909073,0.00241467822619275
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37169,0.00680049442740112,0.00366895084075787,-0.00039064922048431,0.0139916380752866,0.0638291696117231
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37169,0.00924044428794704,0.00359067890646713,0.00220271363127147,0.0162781749446226,0.0100796490546759
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23496.Total Lipids in Large VLDL,37169,0.00954644012907335,0.00359248616068576,0.00250516725412925,0.0165877130040175,0.00788551199851403
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23497.Phospholipids in Large VLDL,37169,0.00882954200653966,0.00361281583914094,0.00174842296182341,0.0159106610512559,0.0145403232931297
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23498.Cholesterol in Large VLDL,37169,0.0120568718361283,0.00352924316471785,0.00513955523328127,0.0189741884389752,0.00063673414315657
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37169,0.0134626463048498,0.00347058439637005,0.0066603008879645,0.0202649917217351,0.000105360585346224
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37169,0.0103125130759712,0.0035958684436248,0.0032646109264666,0.0173604152254758,0.00413883749288681
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23501.Triglycerides in Large VLDL,37169,0.00822931806177971,0.00361264457739482,0.00114853469008586,0.0153101014334736,0.0227470818500333
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37169,0.0165943808783527,0.00343377678323179,0.00986417838321836,0.023324583373487,1.36203071154271e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37169,0.0151718206402233,0.00344659998583031,0.00841648466799585,0.0219271566124507,1.08109438982808e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37169,0.0168860851554088,0.00343475003199654,0.0101539750926956,0.023618195218122,8.92702157677274e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37169,0.0184574187133226,0.00346967976698273,0.0116568463700364,0.0252579910566087,1.05661757018267e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37169,0.018292109125828,0.00351026390478711,0.0114119918724452,0.0251722263792107,1.90596750114589e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37169,0.017658979559087,0.0034328623467337,0.0109305693594889,0.024387389758685,2.72630546274498e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37169,0.00975603883120618,0.00353553454650474,0.00282639112005689,0.0166856865423555,0.0057982509153858
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37169,0.01177374950319,0.00344812815151249,0.0050154183262255,0.0185320806801544,0.00064081915302763
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23510.Total Lipids in Small VLDL,37169,0.0127049131166273,0.00344009756454541,0.00596232189011828,0.0194475043431363,0.000222349718274457
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23511.Phospholipids in Small VLDL,37169,0.0153282137785418,0.00341703139220632,0.00863083224981736,0.0220255953072661,7.32397685096293e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23512.Cholesterol in Small VLDL,37169,0.0154504209959735,0.00342454818627739,0.00873830655086984,0.0221625354410772,6.48708369742793e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37169,0.0145702986418638,0.00343060382645764,0.00784631514200678,0.0212942821417207,2.1797520033046e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37169,0.0166640110120249,0.00342654897814477,0.00994797501486109,0.0233800470091886,1.16820514812349e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23515.Triglycerides in Small VLDL,37169,0.00599915650306936,0.00348819363137964,-0.000837703014434736,0.0128360160205735,0.0854836535132438
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37169,0.0187247871097945,0.00344881936131884,0.0119651011616096,0.0254844730579795,5.75574600925952e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37169,0.0186322770178379,0.00343778835204201,0.0118942118478356,0.0253703421878403,6.06902793473648e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37169,0.0170840692595297,0.00341639137228781,0.0103879421698456,0.0237801963492138,5.78745737567945e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37169,0.0220614608064213,0.00356391443649236,0.0150761885108963,0.0290467331019463,6.18400015630618e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37169,0.0229289296467027,0.0036106265970106,0.0158521015165619,0.0300057577768434,2.21733109522844e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37169,0.0192715574721576,0.00346202606239961,0.0124859863898543,0.0260571285544608,2.64850407877209e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37169,0.0072147256411443,0.00339150300655507,0.000567379748296368,0.0138620715339922,0.0334139575635378
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23523.Concentration of IDL Particles,37169,0.020040618456661,0.00354477706661951,0.0130928554060867,0.0269883815072352,1.60385924955026e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23524.Total Lipids in IDL,37169,0.0222343926861878,0.0036261967027091,0.015127047148878,0.0293417382234977,8.94600176914408e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23525.Phospholipids in IDL,37169,0.0219478354594507,0.00362368913637026,0.014845404752165,0.0290502661667364,1.42628790771472e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23526.Cholesterol in IDL,37169,0.0220615774731765,0.00364944335807392,0.0149086684913516,0.0292144864550014,1.53225925157677e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37169,0.0217855917417927,0.00364551622058578,0.0146403799494445,0.0289308035341408,2.34533382063313e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23528.Free Cholesterol in IDL,37169,0.022012952124992,0.00364476099552747,0.0148692205737582,0.0291566836762258,1.58599657034551e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23529.Triglycerides in IDL,37169,0.00972765487033903,0.0033471308197846,0.00316727846356122,0.0162880312771168,0.00366372660527343
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23530.Concentration of Large LDL Particles,37169,0.0179567408212484,0.00345827401309738,0.0111785237555776,0.0247349578869193,2.10660963620846e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23531.Total Lipids in Large LDL,37169,0.0178979656796205,0.00347436372629339,0.0110882127760854,0.0247077185831555,2.62193012698844e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23532.Phospholipids in Large LDL,37169,0.0184731851023533,0.00348377837002944,0.0116449794970956,0.025301390707611,1.15972653275902e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23533.Cholesterol in Large LDL,37169,0.017592480778615,0.00348065764779596,0.0107703917889349,0.024414569768295,4.37579703311964e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37169,0.0172146210590426,0.00346104092567467,0.0104309808447202,0.0239982612733649,6.64624896035847e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37169,0.0181864363088516,0.00353858222310142,0.0112508151515728,0.0251220574661303,2.79417499120225e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23536.Triglycerides in Large LDL,37169,0.00996011322760701,0.00335850352449343,0.00337744631959988,0.0165427801356141,0.00302589687527058
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37169,0.0167336206014721,0.00343186409375538,0.0100071669777115,0.0234600742252326,1.09533014495435e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23538.Total Lipids in Medium LDL,37169,0.0158037352517286,0.0034171375761238,0.00910614560252591,0.0225013249009312,3.7840729308751e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23539.Phospholipids in Medium LDL,37169,0.0153479953493851,0.00341237014226606,0.00865974987054362,0.0220362408282266,6.92567502280646e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23540.Cholesterol in Medium LDL,37169,0.0159532848869801,0.00341811316980373,0.00925378307416475,0.0226527866997954,3.08193450356592e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37169,0.015944102265899,0.00342247046776331,0.00923606014908293,0.0226521443827151,3.21368084816298e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37169,0.0148867614317599,0.00342103059542061,0.0081815414647355,0.0215919813987843,1.36190581422832e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23543.Triglycerides in Medium LDL,37169,0.00849645916862433,0.00340464890617267,0.0018233473125259,0.0151695710247228,0.0125883449679597
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23544.Concentration of Small LDL Particles,37169,0.0170892979781708,0.00344622328528331,0.0103347003390155,0.023843895617326,7.17866203486164e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23545.Total Lipids in Small LDL,37169,0.0164951328551534,0.00344279864749011,0.00974724750607274,0.023243018204234,1.67577046973257e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23546.Phospholipids in Small LDL,37169,0.0157076217518609,0.00345290329510501,0.0089399312934551,0.0224753122102667,5.43505646063546e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23547.Cholesterol in Small LDL,37169,0.0165747868920425,0.00343668892647988,0.00983887659614194,0.0233106971879431,1.43056547122265e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37169,0.0169739055600415,0.00343808813811473,0.0102352528093366,0.0237125583107463,8.02872625429294e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37169,0.0139968089037961,0.00342909358872083,0.00727578546990328,0.0207178323376889,4.49529043214483e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23550.Triglycerides in Small LDL,37169,0.0085778974869369,0.0034498156369395,0.00181625883853547,0.0153395361353383,0.0129135491093981
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37169,0.0131412194931359,0.00403657119119225,0.00522953995839908,0.0210528990278727,0.0011345980441852
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37169,0.0118406013556395,0.00404559843048872,0.00391122843188163,0.0197699742793974,0.00343063670756098
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37169,0.0105635393635012,0.00399675575248886,0.00272989808862304,0.0183971806383794,0.00822643571928888
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37169,0.0119795444016367,0.00411352151608483,0.00391704223011044,0.020042046573163,0.00359447836355994
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37169,0.0119807202225951,0.00416503274325153,0.00381725604582213,0.0201441843993682,0.0040274984533525
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37169,0.0117229299734154,0.00386453455987496,0.00414844223606047,0.0192974177107703,0.00242228855122574
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37169,0.00869593676312765,0.00328021456141867,0.00226671622274705,0.0151251573035082,0.00803424791396386
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23558.Concentration of Large HDL Particles,37169,0.0108578468184295,0.00413685373235284,0.00274961350301789,0.018966080133841,0.0086833863294917
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23559.Total Lipids in Large HDL,37169,0.00994645310729997,0.00407383655575645,0.00196173345801732,0.0179311727565826,0.014637520237865
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23560.Phospholipids in Large HDL,37169,0.00897026048716679,0.00398477069358023,0.00116010992774955,0.016780411046584,0.0243931763934484
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23561.Cholesterol in Large HDL,37169,0.00998586298338786,0.00417347712380196,0.00180584782073601,0.0181658781460397,0.0167388605211287
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37169,0.00928167798397015,0.00418178121176466,0.00108538680891142,0.0174779691590289,0.0264660311099824
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37169,0.0117647291397233,0.00411499556956255,0.00369933782338074,0.0198301204560659,0.00425653147861736
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23564.Triglycerides in Large HDL,37169,0.00681676748531058,0.00331092637414719,0.000327351791982079,0.0133061831786391,0.0395260948272251
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37169,0.00781088488914882,0.00364022838042375,0.00067603726351828,0.0149457325147794,0.0319139269784962
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23566.Total Lipids in Medium HDL,37169,0.00776120074170592,0.00358139774717934,0.000741661157234421,0.0147807403261774,0.0302458945601114
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23567.Phospholipids in Medium HDL,37169,0.00807480832332984,0.00352118830649596,0.00117327924259777,0.0149763374040619,0.0218516938572919
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23568.Cholesterol in Medium HDL,37169,0.00646237124638163,0.00369553577198016,-0.00078087886669949,0.0137056213594627,0.080366512291494
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37169,0.00553729270159006,0.00368707055124578,-0.00168936557885168,0.0127639509820318,0.133168978914178
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37169,0.00983777337513705,0.00370762635522423,0.00257082571889756,0.0171047210313765,0.00797827256572498
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23571.Triglycerides in Medium HDL,37169,0.00635426912928691,0.00335617234938169,-0.000223828675501203,0.012932366934075,0.0583385464620454
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23572.Concentration of Small HDL Particles,37169,0.00746067954265999,0.00331953259282402,0.00095439566072492,0.0139669634245951,0.024623822730074
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23573.Total Lipids in Small HDL,37169,0.00810322194784575,0.00333979801136385,0.00155721784557259,0.0146492260501189,0.0152684877100645
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23574.Phospholipids in Small HDL,37169,0.00822019653041096,0.0033463739982784,0.0016613034937853,0.0147790895670366,0.0140444552789873
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23575.Cholesterol in Small HDL,37169,0.00693363247661584,0.00331541912338978,0.000435410994771878,0.0134318539584598,0.0365174847199382
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37169,0.00518974019154104,0.00330044861105942,-0.00127913908613543,0.0116586194692175,0.115873523921022
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37169,0.0109841313074828,0.00337315301206583,0.00437275140383373,0.0175955112111318,0.00113141090234541
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23578.Triglycerides in Small HDL,37169,0.00441308582768385,0.00360691768930438,-0.00265647284335274,0.0114826444987204,0.22116025942161
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36538,-0.00769301844180667,0.00337841414490468,-0.0143147101658198,-0.0010713267177935,0.0227962792028825
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36538,-6.35654387329049e-07,0.00337134506740011,-0.00660847198649153,0.00660720067771688,0.999849564845054
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36538,0.00249571792192043,0.00334178714153175,-0.0040541848754818,0.00904562071932266,0.455185266744313
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36538,-0.0047099239930318,0.00341779578079767,-0.0114088037233952,0.00198895573733164,0.168209415174505
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36538,0.00203241245214672,0.00330578435985743,-0.00444692489317385,0.00851174979746728,0.538694600907993
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,37005,0.0108960570647263,0.0032763419856997,0.00447442677275493,0.0173176873566977,0.000884454606408658
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,37005,0.00595871625419359,0.00368444304572948,-0.00126279211543618,0.0131802246238234,0.105845350567696
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,37005,0.00466934650815095,0.00366976241223024,-0.00252338781982031,0.0118620808361222,0.203259267831511
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,37005,0.00902384243681832,0.00351436037091922,0.00213569610981665,0.01591198876382,0.0102483612886251
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,37005,-0.00907577419211608,0.00357185833314339,-0.0160766165250771,-0.00207493185915503,0.0110678017419735
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37165,0.0011774932471819,0.00356432417716999,-0.00580858214007129,0.00816356863443508,0.741136742949927
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37165,0.00694752163294882,0.00342422632911246,0.000236038027888396,0.0136590052380092,0.0424851103353717
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37165,0.00780878809908348,0.00357479625091999,0.000802187447280309,0.0148153887508867,0.02895019661071
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37165,0.00411784904978511,0.00333806173919641,-0.00242475195903985,0.0106604500586101,0.217371987804604
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37165,-0.00580990766952023,0.00328627434474338,-0.0122510053852173,0.000631190046176795,0.0770952835661118
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37169,0.0135353144946984,0.00360497276796502,0.00646956786948695,0.0206010611199098,0.000174341437776112
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37169,0.010633939834859,0.00376254577633239,0.00325935011324747,0.0180085295564704,0.00471649226683977
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37169,0.00952936846124633,0.00377598040401875,0.00212844686936958,0.0169302900531231,0.0116248807059209
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37169,0.0131726500382329,0.00368681499814434,0.00594649264187003,0.0203988074345958,0.000354286541850827
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37169,-0.0114594591845051,0.00373821487100076,-0.0187863603316666,-0.00413255803734359,0.0021774918187357
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37169,0.011123857255245,0.00359425467112599,0.00407911809983803,0.0181685964106519,0.00197287984366001
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37169,0.0102233852628199,0.00346688610367769,0.00342828849961167,0.0170184820260282,0.00319495922867046
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37169,0.00817936765535901,0.00336588427260451,0.00158223448105417,0.0147765008296639,0.0151086260478776
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37169,0.0113728631205046,0.003620453662985,0.00427677394105403,0.0184689522999552,0.00168578991762134
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37169,-0.0106977174406691,0.0035058536157351,-0.0175691905275099,-0.00382624435382833,0.00228235146971884
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37169,-0.00820055498365039,0.00350212603839454,-0.0150647220189037,-0.00133638794839709,0.0192162948924875
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37169,0.0144406315431768,0.00368650425311717,0.00721508320706715,0.0216661798792865,9.0045422066578e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37169,0.0145364448999695,0.00372839055728923,0.00722879940768261,0.0218440903922564,9.71239585091726e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37169,0.00954912084480219,0.00335354915862498,0.00297616449389723,0.0161220771957072,0.00441361254815519
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37169,-0.0132923150832033,0.00364932474924852,-0.0204449915917304,-0.00613963857467625,0.000271129572683979
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37169,-0.00688414702666455,0.00338210907138818,-0.0135130808065854,-0.000255213246743705,0.0418243990451497
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37169,0.0107908013018595,0.00354059781609988,0.00385122958230369,0.0177303730214152,0.0023102588022992
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37169,0.00874983460272928,0.00350382109068344,0.00188234526498973,0.0156173239404688,0.0125288851036451
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37169,0.00656117026152191,0.00345627426170803,-0.000213127291425822,0.0133354678144697,0.0576734309709846
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37169,-0.0102309050933341,0.00357378870642178,-0.0172355309579208,-0.0032262792287474,0.00420622028096946
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37169,-0.00017210231711285,0.0033776223689084,-0.00679224216017331,0.00644803752594761,0.959363188683029
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37169,0.00714245004704765,0.00354604636854565,0.000192199164698178,0.0140927009293971,0.0440085183010186
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37169,0.00294180155013474,0.00333051316618066,-0.00358600425557935,0.00946960735584883,0.377096763882665
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37169,0.00748224700623496,0.0037464833906494,0.000139139560562131,0.0148253544519078,0.0458304417090473
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37169,-0.0079566501131189,0.00346377400122703,-0.0147456471555239,-0.00116765307071393,0.0216282692683755
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37169,-0.00657097650049117,0.00335054806945615,-0.0131380507166252,-3.90228435711432e-06,0.0498806364328575
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37169,0.0118699108970916,0.00347354251931575,0.00506176755923274,0.0186780542349505,0.000634499418149838
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37169,0.0102418253918086,0.00346057940270551,0.0034590897625058,0.0170245610211114,0.00308611872905214
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37169,-0.0014278552776956,0.00363369310933199,-0.00854989377198631,0.0056941832165951,0.694363605060256
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37169,-0.00833050166906919,0.00338407155389939,-0.014963281914712,-0.00169772142342638,0.0138413819514517
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37169,-0.00923072094583092,0.00342240808578551,-0.0159386407939705,-0.00252280109769131,0.0070025493147895
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37169,0.010242679761334,0.00335825651411886,0.003660496993661,0.0168248625290069,0.0022929194238944
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37169,0.0116559862114991,0.00342677556224478,0.00493950610949934,0.0183724663134989,0.000672279226232017
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37169,-0.000924425071809964,0.00346127279166239,-0.00770851974346825,0.00585966959984833,0.789414299082309
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37169,-0.00401702174570826,0.00348009462326824,-0.010838007207314,0.0028039637158975,0.248403984941347
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37164,0.00435574670124941,0.00378954316961956,-0.00307175791120492,0.0117832513137037,0.250406763316752
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37164,-0.00596829713622844,0.00347885485721382,-0.0127868526563675,0.000850258383910655,0.086259944270181
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37164,-0.000498600485389992,0.00332067580160098,-0.00700712505652791,0.00600992408574793,0.880648308114699
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37164,-0.00825931704022412,0.00400531691839015,-0.0161097382002688,-0.000408895880179425,0.0392187064849375
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37164,-0.00165629997091466,0.00373180147044939,-0.00897063085299546,0.00565803091116614,0.657169900989282
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37169,-0.00717602707783263,0.00374612379985449,-0.0145184297255474,0.000166375569882172,0.0554390548174073
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37169,0.00506211181564441,0.00382905460012279,-0.00244283520059626,0.0125670588318851,0.186182033294076
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37169,0.00137398078172867,0.00369797145521017,-0.00587404327048327,0.00862200483394061,0.710233940049333
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37169,0.0164471674246373,0.00374577102348223,0.00910545621861212,0.0237888786306624,1.13772775381684e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37169,-0.00195363972223989,0.00362251687035389,-0.00905377278813352,0.00514649334365374,0.589685772027251
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37169,0.000264198086632009,0.00377476293453402,-0.00713433726505466,0.00766273343831868,0.944202158373921
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37169,-0.00179862988463396,0.00369823907711516,-0.00904717847577967,0.00544991870651174,0.626728708211948
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37169,-0.00496567016791821,0.00353317523241337,-0.0118906936234484,0.001959353287612,0.159913453976349
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37169,0.0143737135675664,0.00399341820895045,0.00654661387802353,0.0222008132571093,0.000320171212660879
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37169,0.00271770003968795,0.00359185920170343,-0.00432234399565078,0.00975774407502667,0.449286355572833
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37169,0.000776117192045372,0.00333096000531777,-0.00575256441837746,0.00730479880246821,0.815764170428135
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37169,-0.000833511891140383,0.00333721072426771,-0.00737444491070509,0.00570742112842433,0.802774459573186
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37169,-0.00339932583427042,0.00327169894799836,-0.00981185577234721,0.00301320410380637,0.298819257869608
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37169,0.00926790433313127,0.00364463141591174,0.00212442675794425,0.0164113819083183,0.0110051413882525
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37169,0.000778780194296978,0.00367343176407518,-0.00642114606329037,0.00797870645188432,0.832107591995677
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47609,0.00521908946142511,0.00283965979442838,-0.000346643735654503,0.0107848226585047,0.0660855393498295
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47609,0.00673123168222489,0.0027789442424745,0.00128450096697486,0.0121779623974749,0.0154331772921875
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,45866,0.00356823452706638,0.00267280738613434,-0.00167046794975692,0.00880693700388968,0.181885666923318
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,45866,0.00641911894896233,0.00289441650471971,0.000746062599711704,0.012092175298213,0.026581425756607
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,45866,0.00297445510568718,0.00286899966726198,-0.00264878424214631,0.00859769445352067,0.299860574086587
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,45866,0.000731290893772356,0.00265096891352094,-0.00446460817672869,0.0059271899642734,0.782659749786384
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24009.Traffic intensity on the nearest road,47609,-0.0562138294566415,0.0691628231064567,-0.191772962745297,0.0793453038320137,0.416355087391569
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24010.Inverse distance to the nearest road,47609,0.00277042667305342,0.00248514686804278,-0.00210046118831043,0.00764131453441728,0.264950014093676
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24011.Traffic intensity on the nearest major road,47609,0.00047259960170429,0.0025077911417678,-0.0044426710361606,0.00538787023956918,0.850523529395149
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24012.Inverse distance to the nearest major road,47609,0.00100898134931298,0.00254568955859131,-0.00398057018552599,0.00599853288415195,0.691851191662653
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24013.Total traffic load on major roads,47609,0.0316494229663552,0.0484327053528466,-0.0632786795252241,0.126577525457935,0.513458279959867
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24015.Sum of road length of major roads within 100m,47609,0.0169941697380298,0.0469477525129738,-0.0750234251873987,0.109011764663458,0.717369842180384
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47609,0.00451606613461334,0.00285106783415567,-0.00107202682033178,0.0101041590895585,0.113209054727232
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47609,0.00468504397819569,0.00285013255578044,-0.000901215831133973,0.0102713037875254,0.100231042021893
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47609,0.00396204852083602,0.00282080754257206,-0.00156673426260522,0.00949083130427726,0.160159426668375
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47562,0.00297376595279349,0.0027258552993213,-0.00236891043387627,0.00831644233946324,0.275306924423314
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24020.Average daytime sound level of noise pollution,47609,0.00269174820911244,0.00249206931764686,-0.00219270765347539,0.00757620407170028,0.280097161050039
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24021.Average evening sound level of noise pollution,47609,0.0027408581871385,0.0024918596236961,-0.00214318667530585,0.00762490304958285,0.271376039269595
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24022.Average night-time sound level of noise pollution,47609,0.0026871861282464,0.002492145943836,-0.00219741992167216,0.00757179217816496,0.280927827003321
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47609,0.00274393877746924,0.00249205710518009,-0.00214049314868373,0.00762837070362221,0.270875699864428
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47609,0.00274364523942692,0.00249220105745606,-0.00214106883318695,0.00762835931204079,0.270954641661101
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2405.Number of children fathered,34487,0.0124273810892253,0.0521317257924828,-0.089750801464041,0.114605563642492,0.811587697136046
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44769,-0.00295713073356678,0.00295879981433611,-0.00875637836966555,0.002842116902532,0.317595145693158
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44769,0.00397035463976123,0.002697457516288,-0.00131666209216324,0.0092573713716857,0.141066246085901
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24502.Water percentage, buffer 1000m",44769,-0.00252364893771504,0.00262728685640564,-0.00767313117627009,0.00262583330084001,0.336787950076414
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44769,-0.00319432933230818,0.0027935092157906,-0.00866960739525775,0.00228094873064139,0.252851344090187
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44769,0.00277362163029539,0.00273746825433109,-0.00259181614819354,0.00813905940878433,0.310973085931236
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24505.Water percentage, buffer 300m",44769,-0.00182400076775633,0.00263608423720556,-0.00699072587267923,0.00334272433716657,0.488985398984646
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",47694,-0.00518597543645268,0.00279847273877713,-0.0106709820044559,0.0002990311315505,0.0638739458060448
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",47694,-0.00637426859530225,0.00263950091402979,-0.0115476903868006,-0.00120084680380387,0.0157447516727168
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24508.Distance (Euclidean) to coast,47694,-9.84709467948178e-05,0.00252128528762377,-0.00504019011053741,0.00484324821694777,0.968846185651695
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28016,-0.062204010423385,0.0807822129569188,-0.220537147818946,0.0961291269721758,0.44133112749458
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2704.Years since last cervical smear test,33866,0.0779308529073358,0.048674284788437,-0.0174707452780007,0.173332451092672,0.109393367506554
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2714.Age when periods started (menarche),36732,-0.022131821329586,0.0430637198747238,-0.106536712284045,0.0622730696248727,0.607308394000956
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2734.Number of live births,37148,-0.00113820433758495,0.0410377272940539,-0.0815721498339305,0.0792957411587606,0.977873478746343
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2744.Birth weight of first child,33869,-0.0169314674443801,0.0466955731225437,-0.108454790764566,0.0745918558758056,0.716916930166108
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2754.Age at first live birth,32151,0.00592570672379317,0.00419477717453114,-0.00229605653828786,0.0141474699858742,0.157799364106249
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2764.Age at last live birth,32127,0.00223354062467063,0.00419952713003539,-0.00599753255019874,0.01046461379954,0.594840530788952
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2794.Age started oral contraceptive pill,35166,0.00325945831026638,0.00420717315385536,-0.00498660107129012,0.0115055176918229,0.438510496108202
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2804.Age when last used oral contraceptive pill,34149,-0.00416455218092891,0.00376523939691416,-0.0115444213988807,0.00321531703702284,0.268729684849234
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2867.Age started smoking in former smokers,28572,0.00899587888613318,0.00551292001621111,-0.0018094443456406,0.019801202117907,0.102792424158425
CCND2,G1/S-specific cyclin-D2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34264,0.0888975769332784,0.0556959558424262,-0.0202664965178769,0.198061650384434,0.11049178905937
CCND2,G1/S-specific cyclin-D2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34258,0.0615848965638809,0.0618757022645747,-0.0596914798746856,0.182861273002447,0.319613463588817
CCND2,G1/S-specific cyclin-D2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,34277,0.0881186475668566,0.0641576593411188,-0.0376303647417363,0.213867659875449,0.16963571333853
CCND2,G1/S-specific cyclin-D2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34252,0.0934010216752929,0.0622611201196863,-0.0286307737592923,0.215432817109878,0.133605926677475
CCND2,G1/S-specific cyclin-D2,Mental health,X28739.Difficulty with standing for long periods,34292,-0.00400521235509268,0.0575226699237226,-0.116749645405589,0.108739220695404,0.944490754574931
CCND2,G1/S-specific cyclin-D2,Mental health,X28740.Difficulty with taking care of household responsibilities,34310,-0.0242192113826762,0.0645175665187564,-0.150673641759439,0.102235218994086,0.707378498987659
CCND2,G1/S-specific cyclin-D2,Mental health,X28741.Difficulty learning a new task,34232,0.144569112727851,0.0734378672483049,0.000630892921172826,0.288507332534528,0.0490266903532035
CCND2,G1/S-specific cyclin-D2,Mental health,X28742.Difficulty with joining in community activities,33848,0.0453032163852546,0.070266407074921,-0.0924189414815905,0.1830253742521,0.519113701820948
CCND2,G1/S-specific cyclin-D2,Mental health,X28743.Difficulty with being emotionally affected by health problems,34235,0.0465666910820125,0.0605637266922475,-0.0721382132347927,0.165271595398818,0.441977618874045
CCND2,G1/S-specific cyclin-D2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,34308,-0.00162985919929539,0.0830076761000294,-0.164324904355353,0.161065185956762,0.9843348848562
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,28440,-0.028515702542578,0.0764982286142825,-0.178452230626572,0.121420825541416,0.709342160536182
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2897.Age stopped smoking,28572,0.010455039649184,0.00663678095357552,-0.00255305101982397,0.0234631303181921,0.115250223219174
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,33134,0.0112326713381977,0.0083302700973272,-0.00509465805256365,0.027560000728959,0.177557478081855
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,33134,-0.010518986515773,0.00893550211677426,-0.0280325706646506,0.00699459763310452,0.239140834472507
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,33134,-0.0624826194102084,0.0300876700314281,-0.121454452671807,-0.00351078614860934,0.0378580918413368
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,33134,-0.00521926066723426,0.0298826620784283,-0.0637892783409538,0.0533507570064853,0.861351798289796
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,33134,-0.0312658104947437,0.0321053561038677,-0.0941923084583244,0.0316606874688371,0.330156276350228
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,33134,-0.000422629715020787,0.0272478261981352,-0.0538283690633659,0.0529831096333243,0.98762517381977
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,33134,-0.0115753971243966,0.0123731943746076,-0.0358268580986276,0.0126760638498343,0.349543644174476
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,33134,0.0185852832359748,0.0224168245813568,-0.0253516929434844,0.0625222594154341,0.407081933878985
CCND2,G1/S-specific cyclin-D2,Mental health,X29002.Recent lack of interest or pleasure in doing things,33083,0.0977041234961184,0.0654568302312787,-0.0305912637571878,0.225999510749425,0.135563096583386
CCND2,G1/S-specific cyclin-D2,Mental health,X29003.Recent feelings of depression,33082,0.104396729363578,0.0630098445458351,-0.0191025659462591,0.227896024673414,0.0975874619705495
CCND2,G1/S-specific cyclin-D2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",33088,0.143212482744711,0.0508892590885889,0.0434695349310769,0.242955430558345,0.00490025311642202
CCND2,G1/S-specific cyclin-D2,Mental health,X29005.Recent feelings of tiredness or low energy,33095,0.0848709642749445,0.0519222611322119,-0.0168966675441908,0.18663859609408,0.102171720357722
CCND2,G1/S-specific cyclin-D2,Mental health,X29006.Recent poor appetite or overeating,33097,0.0797509248324824,0.0694105132125515,-0.0562936810641186,0.215795530729083,0.250596162908629
CCND2,G1/S-specific cyclin-D2,Mental health,X29007.Recent feelings of inadequacy,33064,0.0724254395217338,0.0675949068659342,-0.0600605779354973,0.204911456978965,0.283989413522391
CCND2,G1/S-specific cyclin-D2,Mental health,X29008.Recent trouble concentrating on things,33095,0.173512549971046,0.0683145065787961,0.0396161170766053,0.307408982865486,0.0111044188283764
CCND2,G1/S-specific cyclin-D2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,33085,0.12415393697176,0.122249487202224,-0.1154550579446,0.36376293188812,0.309856841769145
CCND2,G1/S-specific cyclin-D2,Mental health,X29010.Recent thoughts of suicide or self-harm,33032,0.014350042208413,0.132076240380365,-0.244519388937103,0.273219473353929,0.913482726484982
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#0.Substances taken for depression_None of options listed,31456,0.00720538804606555,0.0158445196324648,-0.0238498704335654,0.0382606465256965,0.649297889205479
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31456,-0.00225383351393792,0.0279302298127269,-0.0569970839468826,0.0524894169190067,0.935686536104996
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31456,0.022710614955289,0.0157829194704308,-0.00822390720675545,0.0536451371173334,0.150209788521576
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31456,-0.0338084508189878,0.0460678557347511,-0.1241014480591,0.0564845464211243,0.463042241066142
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31456,0.036956913273774,0.0273323459372648,-0.0166144847632651,0.0905283113108131,0.176373654662304
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31456,0.000702219916186951,0.0291884603633821,-0.056507162396042,0.0579116022284159,0.98080686911837
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31456,-0.0372061092357329,0.0343281940914584,-0.104489369654991,0.0300771511835256,0.278472221834759
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31456,0.00104469990934079,0.0402283851282156,-0.0778029349419617,0.0798923347606433,0.979282568727801
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31456,0.0218725834180575,0.0317353596241947,-0.0403287214453642,0.0840738882814791,0.490707096768568
CCND2,G1/S-specific cyclin-D2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31456,0.00596983164743303,0.016129497294831,-0.0256439830504357,0.0375836463453017,0.711304226236797
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31456,-0.0463852992320279,0.0236705443892958,-0.0927795662350477,8.96777099190782e-06,0.0500766036189544
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31456,-0.000522944755689522,0.0371364782624412,-0.0733104421500744,0.0722645526386953,0.988765169901079
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31456,0.0344393806889329,0.0460513185118077,-0.0558212035942102,0.124699964972076,0.454575072458748
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31456,0.0284439187791417,0.0292778143852052,-0.0289405974158605,0.0858284349741438,0.331321411600018
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31456,-0.0028464036895142,0.0477131107344471,-0.0963641007290305,0.0906712933500021,0.95243067881671
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31456,0.0113825792766346,0.0451531101070308,-0.0771175165331458,0.099882675086415,0.800979487790214
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31456,-0.0146077823202113,0.0244083014380713,-0.0624480531388311,0.0332324884984085,0.549540220931667
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31456,0.00596872057584218,0.0240987719329944,-0.0412648724128269,0.0532023135645112,0.804390732945619
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31456,0.0107963437069669,0.0345265711322595,-0.0568757357122618,0.0784684231261956,0.754519712294762
CCND2,G1/S-specific cyclin-D2,Mental health,X29058.Recent feelings or nervousness or anxiety,32948,0.0569519321925025,0.0596266938794271,-0.0599163878111747,0.17382025219618,0.339531535335442
CCND2,G1/S-specific cyclin-D2,Mental health,X29059.Recent inability to stop or control worrying,32950,0.0709863291244498,0.0625705587705024,-0.051651966065735,0.193624624314635,0.256614593970416
CCND2,G1/S-specific cyclin-D2,Mental health,X29060.Recent worrying too much about different things,32946,0.105782667434261,0.057561859955919,-0.00703857807933989,0.218603912947863,0.0661360933481799
CCND2,G1/S-specific cyclin-D2,Mental health,X29061.Recent trouble relaxing,32950,0.0642449950056867,0.0605649788202657,-0.0544623634820341,0.182952353493408,0.288826512915375
CCND2,G1/S-specific cyclin-D2,Mental health,X29062.Recent restlessness,32952,0.11968775665738,0.0858772845090349,-0.0486317209803281,0.288007234295089,0.163440228859196
CCND2,G1/S-specific cyclin-D2,Mental health,X29063.Recent easy annoyance or irritability,32938,0.0710335138148635,0.0613409931775505,-0.0491948328131354,0.191261860442862,0.246890225361973
CCND2,G1/S-specific cyclin-D2,Mental health,X29064.Recent feelings of foreboding,32932,0.130983393782828,0.0705224320499604,-0.00724057303509465,0.26920736060075,0.0632966792579184
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31456,-0.00518498521962515,0.0162147826914764,-0.0369659592949189,0.0265959888556686,0.749152225974041
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31456,0.0429619303125823,0.0261518636030483,-0.00829572234939244,0.094219582974557,0.100468490223606
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31456,0.0566474475093333,0.0348278547098703,-0.0116151477220125,0.124910042740679,0.103885168229457
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31456,0.0248137129232848,0.0383639455608451,-0.0503796203759716,0.100007046222541,0.517782404446608
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#2.Symptoms of panic attack_Sweating,31456,-0.0410957574639095,0.0244932227251795,-0.0891024740052614,0.0069109590774423,0.093419089232117
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31456,0.0376017037719029,0.0263754650748273,-0.0140942077747586,0.0892976153185644,0.154015720649142
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31456,0.00780886843246684,0.0262229833631426,-0.0435881789592926,0.0592059158242263,0.7658737389461
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31456,-0.0211147741192568,0.0243443890031415,-0.0688297765654141,0.0266002283269006,0.385785129500201
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31456,-0.0332332210143202,0.0319151889989545,-0.0957869914522711,0.0293205494236307,0.297770426672763
CCND2,G1/S-specific cyclin-D2,Mental health,X29076.Felt loved as a child,32911,-0.00138385718484196,0.0531456233290402,-0.105549278909761,0.102781564540077,0.97922683125352
CCND2,G1/S-specific cyclin-D2,Mental health,X29077.Physically abused by family as a child,32913,-0.0128838928578818,0.0691521974520553,-0.14842219986391,0.122654414148147,0.85220417542182
CCND2,G1/S-specific cyclin-D2,Mental health,X29078.Felt hated by family member as a child,32902,-0.00476474357637974,0.070245166804533,-0.142445270513264,0.132915783360505,0.945922304823175
CCND2,G1/S-specific cyclin-D2,Mental health,X29079.Sexually molested as a child,32838,0.0874778978603217,0.0968318619287421,-0.102312551520013,0.277268347240656,0.36633792005664
CCND2,G1/S-specific cyclin-D2,Mental health,X29080.Someone to take to doctor when needed as a child,32900,0.0220760261100626,0.0795936146606052,-0.133927458624723,0.178079510844849,0.781510604405027
CCND2,G1/S-specific cyclin-D2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32898,-0.113163010485444,0.096133595129322,-0.301584856938915,0.075258835968027,0.239169345694365
CCND2,G1/S-specific cyclin-D2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32852,-0.0674116390424074,0.0751146682183237,-0.214636388750322,0.0798131106655071,0.369503014089965
CCND2,G1/S-specific cyclin-D2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32907,-0.30964014145534,0.0801888387768065,-0.466810265457881,-0.1524700174528,0.000113530664161407
CCND2,G1/S-specific cyclin-D2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32873,-0.0053518983541494,0.118725770088192,-0.238054407727006,0.227350611018707,0.964046282892181
CCND2,G1/S-specific cyclin-D2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32874,0.0531382321709146,0.115585036628465,-0.173408439620878,0.279684903962707,0.645719114286271
CCND2,G1/S-specific cyclin-D2,Mental health,X29086.Experienced a violent or sexual assault,32909,-0.0310631987252594,0.092288367653422,-0.211948399325966,0.149822001875448,0.736434969383717
CCND2,G1/S-specific cyclin-D2,Mental health,X29087.Experienced a life-threatening injury or illness,32915,0.0334120865041575,0.0646933370201177,-0.0933868540552732,0.160211027063588,0.605539677436262
CCND2,G1/S-specific cyclin-D2,Mental health,X29088.Experienced a marital separation or divorce,32916,-0.054777406708059,0.0576242433876428,-0.167720923747839,0.0581661103317209,0.341834593906333
CCND2,G1/S-specific cyclin-D2,Mental health,X29089.Experienced the death of a spouse or partner,32925,-0.178238084858918,0.0875296347961939,-0.349796169059458,-0.00668000065837818,0.0417475410567242
CCND2,G1/S-specific cyclin-D2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32912,-0.107286702228678,0.0710677859052462,-0.246579562602961,0.0320061581456044,0.131170467391044
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29091.Frequency of drinking alcohol,32920,0.019236192879826,0.0481022636758216,-0.0750442439247844,0.113516629684436,0.689238107938277
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31982,-0.0445243192135322,0.0538166735824363,-0.150004999435107,0.0609563610080429,0.408072562732992
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31994,-0.00256968272638557,0.0544651908290009,-0.109321456751227,0.104182091298456,0.962370706325027
CCND2,G1/S-specific cyclin-D2,Mental health,X29104.Ever used cannabis,32909,-0.112789532210501,0.064089165043907,-0.238404295696559,0.0128252312755566,0.0784611759526465
CCND2,G1/S-specific cyclin-D2,Mental health,X29108.Ever thought that life not worth living,32869,0.0954711894752902,0.0594585804154884,-0.0210676281390671,0.212010007089647,0.108380266190746
CCND2,G1/S-specific cyclin-D2,Mental health,X29109.Ever contemplated self-harm,32881,0.0692639314440683,0.0782013929009669,-0.0840107986418269,0.222538661529963,0.375796218261347
CCND2,G1/S-specific cyclin-D2,Mental health,X29111.Ever self-harmed,32900,0.0345376708839994,0.124904568146943,-0.210275282684009,0.279350624452007,0.782160803897217
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32907,0.00143693895887811,0.0842429576039935,-0.163679257944949,0.166553135862705,0.98639145442811
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,31982,-0.00197476156238564,0.0326166591279069,-0.0659034134530832,0.0619538903283119,0.951723409799009
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,31982,-0.00238857843619184,0.0260941184851519,-0.0535330506670895,0.0487558937947058,0.927068131425357
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,31982,0.0174438421123601,0.0268608399091854,-0.0352034041096433,0.0700910883343635,0.516088300381301
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,31982,0.0249910045319153,0.0361949330153386,-0.0459510641781483,0.095933073241979,0.48992727250447
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32897,-0.0180799990731145,0.0537881129380551,-0.123504700431703,0.0873447022854735,0.736777828124349
CCND2,G1/S-specific cyclin-D2,Health and medical history,X29153.Pain or discomfort today,32909,-0.051496210767238,0.0513984521021823,-0.152237176887515,0.0492447553530392,0.316417736776691
CCND2,G1/S-specific cyclin-D2,Mental health,X29154.Anxiety or depression today,32909,0.0673703679147829,0.0640348646036538,-0.0581379667083786,0.192878702537944,0.292786883787217
CCND2,G1/S-specific cyclin-D2,Mental health,X29166.Frequency of confiding in someone close,32706,-0.0639610019337268,0.050423607863198,-0.162791273345595,0.0348692694781414,0.204662362880782
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32881,0.00328228778402686,0.00868058468710547,-0.0137316582026999,0.0202962337707536,0.705351623246312
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32881,-0.00451670139388489,0.00864634349965216,-0.0214635346532031,0.0124301318654333,0.601416635164225
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32881,-0.00824578379758663,0.0108179088306192,-0.0294488851056004,0.0129573175104271,0.445939961269798
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32881,0.00517729036223142,0.0127472113901023,-0.0198072439623691,0.0301618246868319,0.684641420646888
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32881,-0.00529013542857326,0.0197556832168514,-0.0440112745336019,0.0334310036764554,0.788876402516172
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32881,0.00252441685453505,0.00930553679012053,-0.0157144352541012,0.0207632689631713,0.786180999445478
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32878,-0.00319958996834453,0.0101373978309581,-0.0230688897170224,0.0166697097803333,0.752296426961006
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32878,-0.0184328765873868,0.0143798919859047,-0.04661746487976,0.00975171170498648,0.199927930876603
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32878,0.00543256079519172,0.0231184832625482,-0.0398796663994027,0.0507447879897862,0.814223562016267
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32878,0.0515301728288205,0.0228747379001202,0.00669568654458489,0.096364659113056,0.0243013181112056
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32878,-0.0149231663445416,0.0305335729787388,-0.0747689693828696,0.0449226366937864,0.625033309129328
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32878,0.00908416966551134,0.0150264888316465,-0.0203677484445158,0.0385360877755385,0.545497411427249
CCND2,G1/S-specific cyclin-D2,Mental health,X29171.Frequency of feeling 'in tune' with people,32718,0.12171199719874,0.0613421381714205,0.00148140638275594,0.241942588014724,0.0472699470010359
CCND2,G1/S-specific cyclin-D2,Mental health,X29172.Freuency of feeling that lacks companionship,32839,0.0242896660116997,0.0564229506282044,-0.086299317219581,0.13487864924298,0.666847639675894
CCND2,G1/S-specific cyclin-D2,Mental health,X29173.Frequency of feeling left out,32791,0.0139745765381883,0.0579017959727678,-0.0995129435684365,0.127462096644813,0.809289696227381
CCND2,G1/S-specific cyclin-D2,Mental health,X29174.Frequency of feeling isolated from others,32821,0.0136247095170942,0.0599390831315532,-0.10385589342075,0.131105312454938,0.820188447753506
CCND2,G1/S-specific cyclin-D2,Mental health,X29175.Tendency to bounce back quickly after hard times,32894,-0.0768463843198415,0.0500962743664257,-0.175035082078036,0.0213423134383529,0.125071069131452
CCND2,G1/S-specific cyclin-D2,Mental health,X29176.Ability to make it through stressful events,32894,0.0555691492961298,0.0491471950012587,-0.0407593529063372,0.151897651498597,0.258224978156128
CCND2,G1/S-specific cyclin-D2,Mental health,X29177.Quick recovery from stressful events,32894,-0.0810979896008315,0.049507436930496,-0.178132565984604,0.0159365867829407,0.101436273599336
CCND2,G1/S-specific cyclin-D2,Mental health,X29178.Hard to snap back when something bad happens,32894,0.0657270993112294,0.0491660080459266,-0.0306382764587868,0.162092475081246,0.181308456466333
CCND2,G1/S-specific cyclin-D2,Mental health,X29179.Comes through difficult times with little trouble,32894,-0.0832908845627885,0.0494293619724189,-0.18017243402873,0.0135906649031526,0.0920137166997517
CCND2,G1/S-specific cyclin-D2,Mental health,X29180.Tendency to take a long time to get over setbacks,32894,0.0706585033292384,0.0492826105835452,-0.0259354134145102,0.167252420072987,0.151680784843889
CCND2,G1/S-specific cyclin-D2,Mental health,X29181.General happiness,32837,0.0482673620210754,0.0516134329825006,-0.0528949666246259,0.149429690666777,0.349725583819525
CCND2,G1/S-specific cyclin-D2,Mental health,X29182.Belief that own life is meaningful,32754,-0.0781730055027821,0.0515699951133279,-0.179250195924905,0.0229041849193406,0.129589753832777
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28170,-0.0654102332971178,0.0738742882770328,-0.210203838320102,0.0793833717258663,0.375976191736777
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2946.Father's age,32519,0.00107143949519362,0.00610643934654016,-0.0108971816240251,0.0130400606144123,0.860721831923678
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2966.Age high blood pressure diagnosed,28308,-0.010486153009056,0.00973603636664386,-0.029568784287678,0.00859647826956597,0.281518401591398
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30000.White blood cell (leukocyte) count,47194,0.00706481794339338,0.00260518608565076,0.00195865321551789,0.0121709826712689,0.0066962199629798
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47194,0.00417188820474877,0.00308176083133017,-0.00186836302465836,0.0102121394341559,0.175833976269372
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30020.Haemoglobin concentration,47194,-0.000522165378620388,0.00328722215456997,-0.00696512080157754,0.00592079004433676,0.873790792701798
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30030.Haematocrit percentage,47194,0.00177141449893636,0.00322244633531263,-0.0045445803182764,0.00808740931614911,0.582522807786349
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30040.Mean corpuscular volume,47194,-0.00389497047408265,0.00260050698789014,-0.00899196417034733,0.00120202322218202,0.134205632670036
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47193,-0.00575445683104714,0.0026060983968131,-0.0108624096888008,-0.000646503973293469,0.02724883824177
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47193,-0.00453375924643871,0.00255472352106419,-0.00954101734772453,0.000473498854847107,0.0759674929211259
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47194,0.00503495890994682,0.00248426838216467,0.000165792880904061,0.00990412493898958,0.0427006544895502
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30080.Platelet count,47194,-0.000384799290839799,0.00262779384016756,-0.00553527521756822,0.00476567663588862,0.883579774803184
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30090.Platelet crit,47194,-0.00139951458777984,0.00269153039748303,-0.00667491416684658,0.00387588499128689,0.603089540010433
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47194,-0.0016652026648309,0.00253080195150088,-0.00662557448977262,0.00329516916011082,0.510561130773332
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30110.Platelet distribution width,47194,0.000614055970006403,0.00251309596558532,-0.00431161212254082,0.00553972406255363,0.806967774647594
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30120.Lymphocyte count,47162,0.0169322365038581,0.00264979610649007,0.0117386361351376,0.0221258368725786,1.69006196296612e-10
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30130.Monocyte count,47162,0.00837114676656719,0.00265631001223786,0.00316477914258099,0.0135775143905534,0.00162684731555515
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30140.Neutrophill count,47162,-0.00175244877004546,0.00258436588617063,-0.00681780590693989,0.00331290836684897,0.497717412791528
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30150.Eosinophill count,47162,0.0137256347906594,0.00252514145625378,0.00877635753640203,0.0186749120449169,5.51632142796657e-08
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30160.Basophill count,47162,0.0167887389869955,0.0346604004119425,-0.0511456458204118,0.0847231237944027,0.628122108733229
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30170.Nucleated red blood cell count,47162,-0.0580518560255284,0.157434390968918,-0.366623262324608,0.250519550273551,0.712327254539559
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30180.Lymphocyte percentage,47162,0.0129843537789308,0.00261002142399257,0.00786871178790535,0.0180999957699562,6.57772277701648e-07
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30190.Monocyte percentage,47162,0.00379773901883204,0.00261558958405381,-0.00132881656591344,0.00892429460357751,0.146525386780826
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30200.Neutrophill percentage,47162,-0.0155116221702296,0.00256768007188074,-0.0205442751111158,-0.0104789692293433,1.5538407587762e-09
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30210.Eosinophill percentage,47162,0.0105746858414883,0.00249023794442691,0.00569381947041154,0.015455552212565,2.18019700525805e-05
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30220.Basophill percentage,47162,0.00314136195506002,0.00249175235685266,-0.0017424726643712,0.00802519657449123,0.207428165361171
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30230.Nucleated red blood cell percentage,47162,-0.0605172816952883,0.157399239356652,-0.369019790834327,0.24798522744375,0.700624237898587
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30240.Reticulocyte percentage,46767,0.000905081388290559,0.00267616709313563,-0.00434020611425527,0.00615036889083639,0.735215102963538
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30250.Reticulocyte count,46767,0.00186957533433613,0.00274629319490318,-0.00351315932767411,0.00725230999634636,0.496028221914778
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30260.Mean reticulocyte volume,46767,0.000632566227260724,0.00258333559420012,-0.0044307715373715,0.00569590399189295,0.80656382839478
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30270.Mean sphered cell volume,46767,8.801458363584e-05,0.00259062739484215,-0.00498961511025478,0.00516564427752646,0.972897992424693
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30280.Immature reticulocyte fraction,46767,0.00546822277953075,0.00269546721494275,0.000185107038242953,0.0107513385208185,0.0425031055149418
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46767,0.00283974581136076,0.00273467240660579,-0.00252021210558659,0.00819970372830811,0.29908428236589
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30300.High light scatter reticulocyte count,46767,0.00346407520855041,0.00278290675078428,-0.00199042202298678,0.0089185724400876,0.213229520457824
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30500.Microalbumin in urine,30869,0.000621102519494391,0.00465940391004047,-0.00851132914418493,0.00975353418317372,0.89395927921378
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47297,-0.00516720844487691,0.00266037461124667,-0.0103815426829204,4.71257931665605e-05,0.0521144466528434
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30520.Potassium in urine,47247,-0.00277791192935091,0.00246478179977754,-0.00760888425691488,0.00205306039821306,0.259736403763775
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30530.Sodium in urine,47247,0.0041563462233851,0.00256470422849946,-0.000870474064473841,0.00918316651124404,0.105118059344878
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30600.Albumin,44884,0.00783426497595935,0.00276642299913664,0.00241207589765154,0.0132564540542672,0.00463146220988886
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30610.Alkaline phosphatase,46835,0.0106748691504561,0.00261520441377104,0.00554906849946485,0.0158006698014473,4.48298720993883e-05
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30620.Alanine aminotransferase,46825,0.01757915186491,0.00276472449016783,0.012160291864181,0.0229980118656389,2.07737703443784e-10
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30630.Apolipoprotein A,44757,0.00324678506118339,0.00302489202955695,-0.00268200331674824,0.00917557343911501,0.283123953099937
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30640.Apolipoprotein B,46684,0.00899040004194695,0.00266017476377438,0.00377645750494916,0.0142043425789447,0.000727055956816794
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30650.Aspartate aminotransferase,46761,0.0264073114819454,0.0025850604034624,0.0213405930911591,0.0314740298727317,1.90986045709677e-24
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30660.Direct bilirubin,43210,-0.00617973177753477,0.00286043309574458,-0.0117861806451941,-0.000573282909875393,0.0307525438805534
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30670.Urea,46830,0.0112658820715556,0.00272853697850794,0.00591794959368008,0.0166138145494312,3.65775090965004e-05
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30680.Calcium,44880,-0.000411915253283614,0.00269734854617335,-0.00569871840378338,0.00487488789721616,0.878627517203029
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30690.Cholesterol,46840,0.0155930527882763,0.00273247479803448,0.0102374021841287,0.0209487033924239,1.16694931072403e-08
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30700.Creatinine,46834,0.0131541438839425,0.0033236749950676,0.00663974089361003,0.019668546874275,7.58990758491269e-05
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30710.C-reactive protein,46768,0.00108766187277197,0.00283508916468618,-0.00446911289001295,0.00664443663555689,0.701246687863953
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30720.Cystatin C,46836,0.00779156771276002,0.00306179153101919,0.0017904563119624,0.0137926791135576,0.0109413287223115
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30730.Gamma glutamyltransferase,46831,0.0072292634480019,0.0028214788991304,0.00169916480570631,0.0127593620902975,0.0104067134501863
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30740.Glucose,44851,-0.00302213574985905,0.00274879122923628,-0.00840976655916216,0.00236549505944406,0.271588051813698
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46667,0.016296360338927,0.00271526661358091,0.0109744377763085,0.0216182829015456,1.98145788229588e-09
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30760.HDL cholesterol,44865,0.00789522742458256,0.00319271915765457,0.0016374978755796,0.0141529569735855,0.0134105792939895
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30770.IGF-1,46730,-0.007058617868273,0.00269035133942229,-0.0123317064935407,-0.0017855292430053,0.00870435142034282
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30780.LDL direct,46792,0.0120324554214596,0.00270263994292108,0.00673528113333425,0.0173296297095849,8.54308402744327e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30790.Lipoprotein A,42312,0.00188086868997505,0.00284200376685423,-0.00368945869305925,0.00745119607300935,0.50810076997286
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30810.Phosphate,44830,0.00658014426250373,0.00268981312456664,0.00130811053835311,0.0118521779866544,0.0144404306795207
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30830.SHBG,44681,-0.00242579459654205,0.0031312632423489,-0.00856307055154589,0.0037114813584618,0.438524811577543
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30840.Total bilirubin,46755,-0.0070852991977198,0.00264797443906099,-0.0122753290982793,-0.00189526929716025,0.00746168306417637
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30850.Testosterone,45006,-0.00119925032375043,0.00442855722617427,-0.009879222487052,0.00748072183955115,0.786548019308669
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30860.Total protein,44868,0.00321809539430571,0.00273819253461241,-0.00214876197353461,0.00858495276214602,0.239902975045953
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30870.Triglycerides,46824,0.00658683100832399,0.00271092418409387,0.0012734196075,0.011900242409148,0.0151174230233191
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30880.Urate,46812,0.00239892423242032,0.00328068874461543,-0.00403122570702593,0.00882907417186657,0.464648712242457
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30890.Vitamin D,45895,0.00650300326503528,0.00283564870458926,0.000945131804040335,0.0120608747260302,0.0218399047002025
CCND2,G1/S-specific cyclin-D2,Physical measures,X3137.Number of measurements made,45976,-0.00875041205669529,0.0396252831480053,-0.0864159670267857,0.0689151429133952,0.825227612887813
CCND2,G1/S-specific cyclin-D2,Physical measures,X3143.Ankle spacing width,37444,-0.00443869135868831,0.00474012257772873,-0.0137293316110366,0.00485194889365999,0.349079519113771
CCND2,G1/S-specific cyclin-D2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37443,-0.000859615704464813,0.00362709868929907,-0.00796872913549098,0.00624949772656136,0.812661794125804
CCND2,G1/S-specific cyclin-D2,Physical measures,X3146.Speed of sound through heel,37444,-0.00242444179008463,0.00353561277218367,-0.00935424282356462,0.00450535924339536,0.492901144817298
CCND2,G1/S-specific cyclin-D2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37444,-0.00190908447332948,0.00356625358148488,-0.00889894149303986,0.00508077254638089,0.592437826173132
CCND2,G1/S-specific cyclin-D2,Physical measures,X3148.Heel bone mineral density (BMD),37434,-0.00173922193551095,0.00357546006488233,-0.00874712366268031,0.00526867979165842,0.626668017569008
CCND2,G1/S-specific cyclin-D2,Health and medical history,X3526.Mother's age at death,33640,0.007674943278471,0.0045837445772554,-0.00130919609294959,0.0166590826498916,0.094087356535044
CCND2,G1/S-specific cyclin-D2,Health and medical history,X3581.Age at menopause (last menstrual period),29423,-0.00238654685643668,0.00648689316412446,-0.0151008574581206,0.0103277637452473,0.712959626515604
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29364,-0.00011105513977103,0.00608198825966681,-0.012031752128718,0.0118096418491759,0.985432357217376
CCND2,G1/S-specific cyclin-D2,Physical measures,X4100.Ankle spacing width (left),31580,-0.00522595768279818,0.00598029813267859,-0.0169473420228482,0.00649542665725186,0.382220374870016
CCND2,G1/S-specific cyclin-D2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),31580,-0.0105251994811015,0.00455448456732155,-0.0194519892330518,-0.00159840972915128,0.0208616718425046
CCND2,G1/S-specific cyclin-D2,Physical measures,X4103.Speed of sound through heel (left),31580,-0.00925368972143354,0.00445549811352374,-0.0179864660239401,-0.000520913418927012,0.0378424220074003
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",31580,-0.00982115699749355,0.00449218629516036,-0.0186258421360079,-0.00101647185897925,0.028825376706491
CCND2,G1/S-specific cyclin-D2,Physical measures,X4105.Heel bone mineral density (BMD) (left),31574,-0.0091524051633197,0.00449711866926347,-0.0179667577550761,-0.000338052571563299,0.0418677929561359
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",31580,-0.00981617672161455,0.0044922442146775,-0.0186209753823824,-0.00101137806084665,0.0289086347148853
CCND2,G1/S-specific cyclin-D2,Physical measures,X4119.Ankle spacing width (right),31569,-0.00124302127729105,0.00586762718319891,-0.0127435705563609,0.0102575280017788,0.832234385366118
CCND2,G1/S-specific cyclin-D2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),31569,-0.00527353655403511,0.00461241887579878,-0.0143138775506007,0.0037668044425305,0.252935336270601
CCND2,G1/S-specific cyclin-D2,Physical measures,X4122.Speed of sound through heel (right),31569,-0.00498719799245889,0.00448322538846026,-0.013774319753841,0.00379992376892322,0.265995325808424
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",31569,-0.00513764920438688,0.00453147033802976,-0.0140193310669252,0.00374403265815146,0.256925916353853
CCND2,G1/S-specific cyclin-D2,Physical measures,X4124.Heel bone mineral density (BMD) (right),31562,-0.00492725767637448,0.0045411952329546,-0.0138280003329655,0.00397348498021654,0.277949680803748
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",31569,-0.00514258007289286,0.00453149680919224,-0.0140243138189097,0.00373915367312392,0.256472446898253
CCND2,G1/S-specific cyclin-D2,Physical measures,X4194.Pulse rate,31844,-0.00371139531973406,0.00435818789462757,-0.0122534435932041,0.00483065295373596,0.394466457172122
CCND2,G1/S-specific cyclin-D2,Physical measures,X4195.Pulse wave reflection index,31844,-0.000750799171130041,0.0042428692182765,-0.00906682283895198,0.0075652244966919,0.859547808753819
CCND2,G1/S-specific cyclin-D2,Physical measures,X4196.Pulse wave peak to peak time,31839,0.00176286388463123,0.00453882589590641,-0.00713323487134532,0.0106589626406078,0.697733030178696
CCND2,G1/S-specific cyclin-D2,Physical measures,X4198.Position of the pulse wave peak,31844,0.00422917234264493,0.00437422414286263,-0.00434430697736581,0.0128026516626557,0.333653598812244
CCND2,G1/S-specific cyclin-D2,Physical measures,X4199.Position of pulse wave notch,31844,0.00011515970538211,0.00429824589975894,-0.0083094022581454,0.00853972166890962,0.978626099258606
CCND2,G1/S-specific cyclin-D2,Physical measures,X4200.Position of the shoulder on the pulse waveform,31844,-0.00231818498741345,0.00447221076340164,-0.0110837180836807,0.00644734810885377,0.604226190061493
CCND2,G1/S-specific cyclin-D2,Physical measures,X4269.Number of triplets attempted (left),31711,-0.18625212893261,0.193459888440775,-0.565433510276528,0.192929252411309,0.335706279100762
CCND2,G1/S-specific cyclin-D2,Physical measures,X4270.Volume level set by participant (left),31632,-0.15688478172205,0.0558369297811503,-0.266325164093105,-0.0474443993509954,0.0049712327462781
CCND2,G1/S-specific cyclin-D2,Physical measures,X4276.Number of triplets attempted (right),31722,0.160217997081543,0.186546619271222,-0.205413376690053,0.525849370853139,0.390442308821792
CCND2,G1/S-specific cyclin-D2,Physical measures,X4277.Volume level set by participant (right),31635,-0.194953131280965,0.055612077332819,-0.30395280285329,-0.0859534597086399,0.00045816614958987
CCND2,G1/S-specific cyclin-D2,Cognitive function,X4288.Time to answer,31865,0.00585517066224994,0.00494769987603705,-0.00384232109478267,0.0155526624192826,0.236680785224749
CCND2,G1/S-specific cyclin-D2,Cognitive function,X4290.Duration screen displayed,31865,-0.00739490214478716,0.00434311928642578,-0.0159074159461817,0.00111761165660737,0.0886685252149594
CCND2,G1/S-specific cyclin-D2,Physical measures,X46.Hand grip strength (left),47896,0.00423388734575571,0.00354615165222897,-0.00271656989261307,0.0111843445841245,0.23251376905027
CCND2,G1/S-specific cyclin-D2,Physical measures,X47.Hand grip strength (right),47877,0.00199577682537936,0.00352081536804747,-0.00490502129599369,0.00889657494675241,0.570820885963627
CCND2,G1/S-specific cyclin-D2,Physical measures,X48.Waist circumference,47946,-0.00625022713690057,0.00554936490228336,-0.017126982345376,0.00462652807157482,0.260051498860995
CCND2,G1/S-specific cyclin-D2,Health and medical history,X4803.Tinnitus,31669,0.0131347673049248,0.0685850833759715,-0.121291996111979,0.147561530721829,0.848130593765183
CCND2,G1/S-specific cyclin-D2,Working and living environment,X4825.Noisy workplace,31795,0.0270730378556045,0.0757832029836825,-0.121462039992413,0.175608115703622,0.720919211904176
CCND2,G1/S-specific cyclin-D2,Working and living environment,X4836.Loud music exposure frequency,31741,0.093329950458293,0.0819262395747823,-0.0672454791082804,0.253905380024866,0.254656524952018
CCND2,G1/S-specific cyclin-D2,Physical measures,X49.Hip circumference,47942,-0.00113043026825778,0.00439199194535286,-0.00973873448114939,0.00747787394463382,0.796884233454004
CCND2,G1/S-specific cyclin-D2,Physical measures,X50.Standing height,47919,-0.00557189601187169,0.00348869311884414,-0.0124097345248062,0.00126594250106283,0.110249892623963
CCND2,G1/S-specific cyclin-D2,Health and medical history,X5057.Number of older siblings,31124,-0.108019019125504,0.0584561134851094,-0.222593001556318,0.00655496330531034,0.0646624743514452
CCND2,G1/S-specific cyclin-D2,Physical measures,X51.Seated height,47803,-0.00157432282438909,0.00323599143918966,-0.00791686604520081,0.00476822039642264,0.626614313048948
CCND2,G1/S-specific cyclin-D2,Eye measures,X5181.Ever had eye surgery,29276,-0.0226422258046138,0.146300059060502,-0.309390341563198,0.26410588995397,0.877011830101781
CCND2,G1/S-specific cyclin-D2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29265,-0.00033219798176339,0.00539301705250481,-0.0109025114046728,0.010238115441146,0.950885407068758
CCND2,G1/S-specific cyclin-D2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29264,-0.00063676858725398,0.00533704857280179,-0.0110973837899455,0.00982384661543753,0.905033406127597
CCND2,G1/S-specific cyclin-D2,Eye measures,X5190.Duration at which refractometer first shown (right),29212,0.00281098025177508,0.00528022376918503,-0.00753825833582758,0.0131602188393777,0.59449874017512
CCND2,G1/S-specific cyclin-D2,Eye measures,X5193.Duration at which refractometer first shown (left),29211,-0.00294482115522703,0.00530183231868717,-0.0133364124998539,0.00744677018939983,0.57862064573032
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5199.logMAR, initial (right)",29241,0.00826040907772473,0.0687443581855849,-0.126478532966022,0.142999351121471,0.904359887884479
CCND2,G1/S-specific cyclin-D2,Eye measures,X5200.Final number of letters displayed (right),29241,0.226534034253727,0.514971374739266,-0.782809860235235,1.23587792874269,0.660029844449974
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5201.logMAR, final (right)",29199,-0.00173883883682869,0.00510849846122289,-0.0117514958208256,0.00827381814716817,0.733582571154339
CCND2,G1/S-specific cyclin-D2,Eye measures,X5202.Number of rounds to result (right),29241,-0.012471403096779,0.0665306353497204,-0.142871448382231,0.117928642188673,0.851312129876399
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5206.logMAR, initial (left)",29241,0.0470923985562971,0.0688058640661803,-0.0877670950134164,0.18195189212601,0.493736819263286
CCND2,G1/S-specific cyclin-D2,Eye measures,X5207.Final number of letters displayed (left),29241,0.218982810448276,0.464281129270048,-0.691008202921018,1.12897382381757,0.637188664444681
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5208.logMAR, final (left)",29199,0.00151120595677941,0.0051421421829174,-0.00856739272173869,0.0115898046352975,0.768856089574342
CCND2,G1/S-specific cyclin-D2,Eye measures,X5209.Number of rounds to result (left),29237,-0.00683495531525668,0.0660958194253758,-0.136382761388993,0.12271285075848,0.917641600767355
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29031,0.00350145053303134,0.00532689696533392,-0.00693926751902315,0.0139421685850858,0.511007497450693
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29031,0.00301014362676009,0.00523385766388025,-0.00724821739444519,0.0132685046479654,0.565229039896288
CCND2,G1/S-specific cyclin-D2,Eye measures,X5256.Corneal hysteresis (right),29031,-0.00235650426936886,0.00535532671824916,-0.0128529446371372,0.00813993609839949,0.659933789886323
CCND2,G1/S-specific cyclin-D2,Eye measures,X5257.Corneal resistance factor (right),29031,-0.00046811542808736,0.00524810774275237,-0.010754406603882,0.00981817574770728,0.92892880961331
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29010,0.00567335877090121,0.00534434247474032,-0.00480155247958983,0.0161482700213922,0.288483680729762
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29010,0.00207544539462807,0.0052336849510653,-0.00818257710945992,0.0123334678987161,0.691711866824741
CCND2,G1/S-specific cyclin-D2,Eye measures,X5264.Corneal hysteresis (left),29010,-0.00646089684446594,0.00532597535640093,-0.0168998085430118,0.00397801485407988,0.225150375797311
CCND2,G1/S-specific cyclin-D2,Eye measures,X5265.Corneal resistance factor (left),29010,-0.00431493115148451,0.0052311539242877,-0.0145679928430884,0.00593813054011937,0.409493456890568
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29077,0.00756681354956638,0.293729884529813,-0.568143760128866,0.583277387227999,0.979448851300405
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",47869,-0.0164878824128675,0.0149969940511736,-0.0458819907531677,0.0129062259274327,0.271599213743678
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",47869,-0.0107225577746119,0.016544988328376,-0.0431507348982288,0.021705619349005,0.516936211314435
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",47869,-0.0336812574215058,0.041107338299817,-0.114251640489147,0.0468891256461356,0.412595444264188
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",47869,-0.00891519884617444,0.00694111173710509,-0.0225197778509004,0.00468938015855154,0.199012665910835
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",47869,0.0133323498692601,0.00622869074956141,0.00112411600011971,0.0255405837384004,0.032326533271813
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35842,-0.00508828514575404,0.00701711140362984,-0.0188418234968685,0.00866525320536044,0.468389313371465
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35842,-0.040699597674235,0.0244610706557675,-0.0886432961595392,0.00724410081106924,0.0961681890511239
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35842,-0.0181559098527154,0.0119830926840372,-0.0416427715134284,0.00533095180799753,0.129766568786663
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35842,0.00777170785136624,0.00758073430408443,-0.00708653138463924,0.0226299470873717,0.305293317830233
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,47935,0.00723515563229417,0.0139868423191175,-0.0201790553131761,0.0346493665777644,0.604963377973188
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,47935,0.00723515563229417,0.0139868423191175,-0.0201790553131761,0.0346493665777644,0.604963377973188
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),47935,-0.000226766419349512,0.0103411916920922,-0.0204955021358502,0.0200419692971512,0.982505203315337
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',47935,-0.0235088195296375,0.0160778928658779,-0.0550214895467583,0.00800385048748322,0.143704157415208
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),47935,-5.23427088618804e-05,0.0393877728493103,-0.0772523774935101,0.0771476920757863,0.998939696502764
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),47935,0.0234528584561078,0.0280856054499002,-0.0315949282256967,0.0785006451379122,0.403698372033766
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,47935,-0.0292727649405901,0.042165092166348,-0.111916345586632,0.053370815705452,0.487537349236247
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,47868,0.0012240748413375,0.00797262954239049,-0.0144022790617479,0.0168504287444229,0.877977962343727
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,47868,0.0110267355098395,0.0136476944017571,-0.0157227455176044,0.0377762165372834,0.419123962301919
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,47868,-1.61770577414009e-05,0.00668143522685111,-0.0131117901023696,0.0130794359868868,0.998068187873612
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,47868,0.0149829685715519,0.012499244763002,-0.00951555116393209,0.0394814883070358,0.230652594932321
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,47868,0.0071794466824734,0.0108796756627598,-0.0141447176165357,0.0285036109814825,0.50932735992027
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,47868,-0.00791390293129401,0.00878492685585475,-0.0251323595687693,0.0093045537061813,0.367677019995622
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29207,-0.0330195459334623,0.0230354003639958,-0.0781689306468941,0.0121298387799695,0.151794549821704
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29207,-0.0128950725327454,0.0200423763103627,-0.0521781301010562,0.0263879850355655,0.51999840190207
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29207,-0.0159065262550906,0.0249958741182609,-0.0648984395268819,0.0330853870167007,0.524565087576933
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29207,0.00526852928473876,0.0204865248460349,-0.0348850594134897,0.0454221179829672,0.797057072104227
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,47830,0.00556168451651557,0.0219545353422922,-0.0374692047543772,0.0485925737874083,0.8000174264668
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,47830,0.0150668930325116,0.0320645914221088,-0.0477797061548216,0.0779134922198449,0.638436498566438
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,47830,-0.109744360092122,0.0675899234615752,-0.24222061007681,0.0227318898925654,0.104457418865196
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,47830,-0.0182077488570228,0.0540714393876037,-0.124187770056726,0.0877722723426804,0.736319586594683
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,47830,0.0010700659757195,0.020315744615098,-0.0387487934698727,0.0408889254213117,0.957993880876086
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,47830,-0.009033710321323,0.0260535770580614,-0.0600987213551233,0.0420313007124773,0.728792785726415
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,47830,0.018778814142292,0.0106155453043206,-0.00202765465417635,0.0395852829387604,0.0769079330196459
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32176,0.0086158601663759,0.020617342842695,-0.0317941318053063,0.0490258521380581,0.676035540491533
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32176,0.00314290511052033,0.0227190629826134,-0.041386458335402,0.0476722685564426,0.889976804889823
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32176,-0.0391813928552902,0.0292569577638341,-0.0965250300724051,0.0181622443618247,0.180536889760152
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32176,0.0101127925607842,0.00886069349187328,-0.0072541666832874,0.0274797518048559,0.253774065551308
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",34023,-0.0134221879035069,0.0095931495993599,-0.0322247611182524,0.00538038531123846,0.161800630185498
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",34023,0.00765152874178999,0.00776264914611181,-0.00756326358458915,0.0228663210681691,0.324311056365787
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",34023,0.00480720376706695,0.00767878137675023,-0.0102432077313635,0.0198576152654974,0.531304517674254
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",34024,-0.00648462676232523,0.0186703023874762,-0.0430784194417786,0.0301091659171281,0.728355811551952
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",34024,-0.00593777661575865,0.0121080332624973,-0.0296695218102533,0.017793968578736,0.623861631885219
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",34024,-0.0193792295485803,0.0152219882385026,-0.0492143264960455,0.0104558673988848,0.203008964918145
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,47868,0.0252996811164889,0.0185115600135772,-0.0109829765101224,0.0615823387431002,0.171733307168392
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,47868,0.021939963142786,0.0120242935243051,-0.00162765216485206,0.045507578450424,0.0680683444623516
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,47868,-0.0457433744222649,0.0369288259354476,-0.118123873255742,0.0266371244112124,0.215472363650144
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,47868,0.0202820839350421,0.0136237738767728,-0.00642051286343253,0.0469846807335168,0.136572331189974
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,47868,0.0374950905681129,0.015048328082568,0.00800036752627975,0.0669898136099461,0.0127220028229702
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),47868,0.0201774549974653,0.0163721342353998,-0.0119119281039183,0.0522668380988489,0.217801809553891
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,47868,-0.00936622017423388,0.00534688679955694,-0.0198461183013655,0.00111367795289772,0.0798356464279612
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,27518,-0.00503040065596976,0.017627286347265,-0.0395798818966092,0.0295190805846696,0.775372415110705
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,27518,-0.0160982373433499,0.0225558538319877,-0.0603077108540458,0.0281112361673461,0.475454825975188
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,27518,0.0215718061397707,0.0166650558580233,-0.0110917033419549,0.0542353156214963,0.195597441120216
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,27518,-0.032236138574826,0.0139383376040318,-0.0595552802787283,-0.0049169968709236,0.0207906347945107
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,47982,0.00375581994639898,0.00573124933640421,-0.00747742875295327,0.0149890686457512,0.512266015691439
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,47982,0.0282597256786258,0.0167717194541701,-0.00461284445154752,0.0611322958087992,0.0920086578497919
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,47982,-0.00449936069425689,0.00577591632307293,-0.0158201566874798,0.00682143529896605,0.435995323886813
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,47982,-0.004630340058881,0.00561885483386637,-0.0156432955332591,0.00638261541549709,0.409906885622998
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,47982,0.00572705664615247,0.00816420679291197,-0.010274788667955,0.0217289019602599,0.483008073409484
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,47982,-0.000418502358479225,0.00831707740714403,-0.0167199740764815,0.0158829693595231,0.959869046200029
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,47982,-0.00744540318420052,0.00621381421292311,-0.0196244790415298,0.00473367267312877,0.230850248966939
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,47982,0.0135896324154883,0.0173858462882185,-0.0204866263094198,0.0476658911403965,0.434428450147653
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,40175,0.00133607277263651,0.00605284657043535,-0.0105275065054168,0.0131996520506898,0.825301837446469
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,40175,0.00258742614515821,0.00635826122989887,-0.00987476586544358,0.01504961815576,0.68405793545849
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,40175,0.0133035707221479,0.00758409438415965,-0.00156125427080506,0.0281683957151008,0.0794251271054987
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,40176,-0.0201481334416424,0.0104488576745652,-0.0406278944837901,0.000331627600505258,0.0538398976370694
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,40176,-0.0123314607831702,0.00672354806712264,-0.0255096149947306,0.00084669342839014,0.066661739785135
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47777,-0.0170662207695278,0.00633894201061841,-0.0294905471103399,-0.00464189442871575,0.00710142733019297
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47777,0.00360975037355543,0.00497727815476709,-0.00614571480978806,0.0133652155568989,0.468308308983545
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47777,0.00730097749925103,0.00593464020339572,-0.00433091729940459,0.0189328722979066,0.218622768109123
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47777,0.0183995337538747,0.00922834969679904,0.000311968348148631,0.0364870991596009,0.0461846578218781
CCND2,G1/S-specific cyclin-D2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47792,-0.0122748015802374,0.00544672062852935,-0.0229503740121549,-0.00159922914831984,0.0242295224245544
CCND2,G1/S-specific cyclin-D2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47792,-0.00970043790641727,0.00753652845014425,-0.0244720336687,0.00507115785586547,0.198063923905978
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),47868,0.0128093622237484,0.00577353500752195,0.00149323360900541,0.0241254908384915,0.026520937327525
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,47868,0.00518594147157083,0.0071399889972998,-0.00880843696313678,0.0191803199062784,0.467647585230823
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,47868,0.00981386332493443,0.0106008512506679,-0.0109638051263746,0.0305915317762434,0.354579079381152
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,47868,0.00193797518109109,0.0125372988288946,-0.0226351305235423,0.0265110808857244,0.877156282589362
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,47868,-0.00461201779064534,0.0122186454896305,-0.028560562950321,0.0193365273690303,0.705837075799065
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,47868,0.0253409136107333,0.0177078673011632,-0.00936650629954662,0.0600483335210132,0.152427767144345
CCND2,G1/S-specific cyclin-D2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37444,-0.00190944251587595,0.00356627947065297,-0.00889935027835576,0.00508046524660387,0.592371104872321
CCND2,G1/S-specific cyclin-D2,Physical activities,X864.Number of days or week walked 10+ minutes,47533,-0.00368126447864664,0.0311723700013247,-0.0647791096812431,0.0574165807239499,0.905994316536232
CCND2,G1/S-specific cyclin-D2,Physical activities,X874.Duration of walks,44388,0.00662352903748595,0.00259156413928998,0.00154406332447759,0.0117029947504943,0.0106014271302276
CCND2,G1/S-specific cyclin-D2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46891,0.0932928015066223,0.0300187171049298,0.0344561159809599,0.152129487032285,0.00188701571116277
CCND2,G1/S-specific cyclin-D2,Physical activities,X894.Duration of moderate activity,41682,0.0908481497377624,0.0362089914674468,0.0198785264615667,0.161817773013958,0.0121163491338488
CCND2,G1/S-specific cyclin-D2,Physical activities,X90087.No-wear time bias adjusted average acceleration,29161,0.0225511453061537,0.00543192535970209,0.0119045716011376,0.0331977190111698,3.35349796587105e-05
CCND2,G1/S-specific cyclin-D2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46909,0.0699548373054959,0.0307248353988209,0.00973415992380694,0.130175514687185,0.0228062631255892
CCND2,G1/S-specific cyclin-D2,Physical activities,X914.Duration of vigorous activity,37421,0.000882143462824715,0.00339043308807555,-0.00576310538980337,0.0075273923154528,0.794724198567367
